1
|
Martin A, Carton M, Thery L, Burnod A, Daniel C, Du Rusquec P, Girard N, Bouleuc C. Palliative care integration and end-of-life care intensity for patients with NSCLC. Lung Cancer 2024; 192:107800. [PMID: 38728972 DOI: 10.1016/j.lungcan.2024.107800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 02/15/2024] [Accepted: 04/23/2024] [Indexed: 05/12/2024]
Abstract
BACKGROUND Non-small cell lung cancer (NSCLC) without oncogenic driver mutations is considered to have a poor prognosis, although recent therapeutic progress. This study aims to assess the real-life integration of palliative care (PC) and the intensity of end-of-life (EOL) care for this population. METHODS This was an observational cohort study of decedent patients from metastatic NSCLC without oncogenic driver mutations over the period 01/2018 to 12/2022, treated in first line with immunotherapy +/- chemotherapy. We analysed PC integration and aggressiveness criteria of EOL care in the last month before death: systemic anti-cancer treatment administration, emergency room visits, intensive care unit admission, hospitalization, hospitalization duration > 14 days, and hospital death. RESULTS Among 149 patients, 75 (50 %) met the PC team at least once, and the median time from the first encounter to death was 2.3 months. In the last month before death, at least one criterion of aggressive EOL care was present for 97 patients (70 %). For patients with PC use < 30 days and for patients with PC use < 90 days before death, there were significant changes: increase in the frequency of systemic anti-cancer treatment (respectively 51.1 % vs 20 %; p < 0.001 and 58.7 % vs 6.2 %; p < 0.001); decrease in hospitalization lasting > 14 days (respectively 30 % vs 7 %; p = 0.001 and 36 % vs 6.2 %; p = 0.018) and in death hospitalisation (respectively 66 % and 18 %; p < 0.001 and 58.7 % and 10.3 %; p < 0.001). After adjusting for the factors tested, patients with no PC or late PC use in the last month before death or in the last three month before death, the odds ratio (OR) remained significantly greater than 1 (respectively OR = 3.97 [1.70; 9.98]; p = 0.001 and OR = 23.1 [5.21-177.0], p < 0.0001). CONCLUSION PC is still insufficiently integrated for patients with NSCL cancer. Cancer centres should monitor key indicators such as PC use and aggressiveness criteria of EOL care.
Collapse
Affiliation(s)
- A Martin
- Palliative care Department, Institut Curie, Paris, France
| | - M Carton
- Biostatistics Department, Institut Curie, Paris, France
| | - L Thery
- Palliative care Department, Institut Curie, Paris, France
| | - A Burnod
- Palliative care Department, Institut Curie, Paris, France
| | - C Daniel
- Oncology Department, Institut Curie, Paris, France
| | - P Du Rusquec
- Oncology Department, Institut Curie, Paris, France
| | - N Girard
- Oncology Department, Institut Curie, Paris, France
| | - C Bouleuc
- Supportive care Department, Institut Curie, Paris, France.
| |
Collapse
|
2
|
Hassett K, Muria-Gonzalez MJ, Martin A, Karakaya A, Çelik Oğuz A, Bakonyi J, Knight NL, Prins R, Ellwood SR. Global spread, genetic differentiation and selection of barley spot form of net blotch isolates. Phytopathology 2024. [PMID: 38619562 DOI: 10.1094/phyto-11-23-0442-r] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/16/2024]
Abstract
Spot form of net blotch, caused by Pyrenophora teres f. maculata, is a significant necrotrophic disease of barley that spread world-wide in the 20th century. Genetic relationships were analysed to determine the diversity, survival and dispersal of a diverse collection of 346 isolates from Australia, Southern Africa, North America, Asia Minor and Europe. The results, based on genome-wide DArTseq data, indicated isolates from Turkey were the most differentiated with regional sub-structuring, together with individuals closely related to geographically distant genotypes. Elsewhere, population subdivision related to country of origin was evident, although low levels of admixturing was found that may represent rare genotypes or migration from unsampled populations. Canadian isolates were the next most diverged and Australian and South African the most closely related. With the exception of Turkish isolates, multiple independent Cyp51A mutation events (which confer insensitivity to demethylation inhibitor fungicides) between countries and within regions was evident, with strong selection for a transposable element insertion at the 3' end of the promoter and counter-selection elsewhere. Individuals from Western Australia shared genomic regions and Cyp51A haplotypes with South African isolates, suggesting a recent common origin.
Collapse
Affiliation(s)
- K Hassett
- Curtin University, 1649, Department of Environment and Agriculture, Bentley, Western Australia, Australia;
| | - M J Muria-Gonzalez
- Curtin University, 1649, Department of Environment and Agriculture, Bentley, Western Australia, Australia;
| | - A Martin
- University of Southern Queensland, 7932, Centre for Crop Health, Toowoomba, Queensland, Australia;
| | - A Karakaya
- Ankara University, 37504, Department of Plant Protection, Ankara, Ankara, Turkey;
| | - A Çelik Oğuz
- Ankara University, 37504, Department of Plant Protection, Ankara, Ankara, Turkey;
| | - J Bakonyi
- Centre for Agricultural Research, Budapest, Hungary;
| | - N L Knight
- University of Southern Queensland, Centre for Crop Health, Toowoomba, Queensland, Australia;
| | - R Prins
- CenGen (Pty) Ltd, Worcester 6850, South Africa;
| | - S R Ellwood
- Curtin University, 1649, Department of Environment and Agriculture, Perth, Western Australia, Australia;
| |
Collapse
|
3
|
Kular S, Maiter A, Martin A, Dyde R, Waterworth A, Radatz MWR, Cahill J, Tse GH. Trans-radial cerebral angiography for stereotactic radiosurgery treatment of arteriovenous malformations. Clin Radiol 2024:S0009-9260(24)00196-X. [PMID: 38710602 DOI: 10.1016/j.crad.2024.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 03/21/2024] [Accepted: 04/06/2024] [Indexed: 05/08/2024]
Abstract
OBJECTIVES The popularity of trans-radial access (TRA) for cerebral angiography is growing. Potential benefits of TRA over traditional trans-femoral access (TFA) are multitude. This study aimed to evaluate discharge outcomes and patient opinion of TRA compared to TFA in patients undergoing cerebral angiography prior to stereotactic radiosurgery (SRS) treatment for cerebral arteriovenous malformations. METHODS Consecutive patients treated at the National Centre for Stereotactic Radiosurgery (Sheffield, United Kingdom) over a 22-month period were included. All patients underwent cerebral angiography with either TRA or TFA as part of treatment planning prior to SRS. TRA patients who had previously undergone TFA in other centres were surveyed for their experience of cerebral angiography using a questionnaire. SRS staff at our centre was approached for their opinion. RESULTS 492 patients were included (median age = 43 years, 57.5% male, median lesions treated = 1). More patients underwent angiography with TFA (75.2%) than TRA (24.8%). No difference was found in accumulated dose for angiography between the groups (p>0.05). There was 17.6% reduction in overnight stay between TRA and TRF, the proportion of patients requiring overnight admission was higher for the TFA (35.2%) than TRA (17.6%, p<0.05). 101 patients were surveyed, with a response rate of 47%. Most respondents (79%) indicated preference for TRA over TFA. CONCLUSIONS Use of TRA in pre-SRS cerebral angiography is feasible and improves both patient and staff experience. The adoption of TRA could have important implications for department resources and costs by reducing the proportion of overnight admissions.
Collapse
Affiliation(s)
- S Kular
- Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - A Maiter
- Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK
| | - A Martin
- Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - R Dyde
- Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - A Waterworth
- Scientific Computing, Department of Medical Physics, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - M W R Radatz
- National Centre for Stereotactic Radiosurgery, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - J Cahill
- National Centre for Stereotactic Radiosurgery, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - G H Tse
- Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK.
| |
Collapse
|
4
|
Abugamza A, Kaskirbayeva D, Charlwood A, Nikolova S, Martin A. Impact of the COVID-19 pandemic on employment and inequalities: a systematic review of international evidence and critical appraisal of statistical methods. Perspect Public Health 2024:17579139241231910. [PMID: 38476083 DOI: 10.1177/17579139241231910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/14/2024]
Abstract
AIMS To assess the impact of the COVID-19 pandemic on individual labour market outcomes and how these vary over time and between different groups of individuals. METHODS Searches were conducted using Medline, Scopus and EconLit. Grey literature searches used Google Scholar and Econpapers. Study quality was assessed using the risk of bias in non-randomised studies of exposure tool (ROBINS-E), accompanied by a directed acyclic graph (DAG) to identify relevant mediators, moderators and confounders. RESULTS A total of 85 studies (77 peer-reviewed articles, 8 working papers) were included. The ROBINS-E showed that the overall risk of bias varied between studies from low (n = 14), moderate (n = 56) to serious (n = 15). Studies also varied in terms of outcome measures, study designs and the academic disciplines of researchers. Generally, studies using data collected before and during the pandemic showed large negative effects on employment, working hours and income. Studies that assessed moderators (e.g. by industry, occupation, age, gender, race and country of birth) indicated the pandemic has likely worsened pre-existing disparities in health and work. Generally, women, less educated, non-whites and young workers were affected the most, perhaps due to their jobs involving high levels of personal contact (e.g. hospitality, sales and entertainment) and being less amenable to remote working. The DAG highlighted methodological challenges in drawing robust inferences about COVID-19's impact on employment, including the lack of an unexposed control group. CONCLUSIONS The COVID-19 health crisis caused unanticipated and unprecedented changes to employment opportunities around the world, with potential long-term health consequences. Further research should investigate the longer-term impact of COVID-19, with greater attention given to low- and middle-income countries. Our study provides guidance on the design and critical appraisal of future studies.
Collapse
Affiliation(s)
- A Abugamza
- Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, UK; Department of Health Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Saudi Arabia
| | | | - A Charlwood
- Leeds University Business School, University of Leeds, UK
| | - S Nikolova
- Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, UK; Real World Methods and Evidence Generation, IQVIA, UK
| | - A Martin
- Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, UK
| |
Collapse
|
5
|
Homo RL, Colby DJ, Romo ML, Moreland S, Follen H, Hernandez B, Robinson D, Liesemer K, Paudel M, Crowell TA, Martin A, Armendi IF, Martinez-Bucki E, Bay J, Faestel P, Sainato R. COVID-19 mRNA vaccination and myocarditis/pericarditis in the setting of active surveillance at a military treatment facility. BMJ Mil Health 2023:e002599. [PMID: 37973371 DOI: 10.1136/military-2023-002599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Accepted: 10/27/2023] [Indexed: 11/19/2023]
Affiliation(s)
- Richelle L Homo
- Pediatrics, Brooke Army Medical Center, Fort Sam Houston, Texas, USA
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - D J Colby
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
- Global Infectious Diseases, Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, USA
| | - M L Romo
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
- Global Infectious Diseases, Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, USA
| | - S Moreland
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
- Global Infectious Diseases, Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, USA
| | - H Follen
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - B Hernandez
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - D Robinson
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - K Liesemer
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - M Paudel
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
- Global Infectious Diseases, Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, USA
| | - T A Crowell
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
- Global Infectious Diseases, Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, USA
| | - A Martin
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - I F Armendi
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - E Martinez-Bucki
- Pediatrics, Brooke Army Medical Center, Fort Sam Houston, Texas, USA
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - J Bay
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - P Faestel
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| | - R Sainato
- Pediatrics, Madigan Army Medical Center, Tacoma, Washington, USA
| |
Collapse
|
6
|
Griffiths C, Radley D, Gately P, South J, Sanders G, Morris MA, Clare K, Martin A, Heppenstall A, McCann M, Rodgers J, Nobles J, Coggins A, Cooper N, Cooke C, Gilthorpe MS, Ells L. A complex systems approach to obesity: a transdisciplinary framework for action. Perspect Public Health 2023; 143:305-309. [PMID: 37395317 PMCID: PMC10683338 DOI: 10.1177/17579139231180761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/04/2023]
Affiliation(s)
- C Griffiths
- Obesity Institute, School of Sport, Leeds Beckett University, Headingly Campus, Leeds LS6 3QS, Yorkshire, UK
| | - D Radley
- Obesity Institute, School of Sport, Leeds Beckett University, Leeds, UK
| | - P Gately
- Obesity Institute, School of Sport, Leeds Beckett University, Leeds, UK
| | - J South
- Centre for Health Promotion Research, School of health, Leeds Beckett University, UK
| | - G Sanders
- Obesity Institute, School of Sport, Leeds Beckett University, Leeds, UK
| | - MA Morris
- Leeds Institute for Data Analytics and Leeds Institute for Medical Research, University of Leeds, Leeds, UK
| | - K Clare
- Obesity Institute, School of Health, Leeds Beckett University, Leeds, UK
| | - A Martin
- Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK
| | - A Heppenstall
- School of Political and Social Sciences, MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK
| | - M McCann
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK
| | - J Rodgers
- International Business School, Teesside University, Middlesbrough, UK
| | - J Nobles
- Obesity Institute, School of Health, Leeds Beckett University, Leeds, UK
| | - A Coggins
- Essex County Council, Chelmsford, UK
| | - N Cooper
- Suffolk County Council, Ipswich, UK
| | - C Cooke
- Obesity Institute, School of Sport, Leeds Beckett University, UK
| | - MS Gilthorpe
- Obesity Institute, School of Sport, Leeds Beckett University, Leeds, UK
| | - L Ells
- Obesity Institute, School of Health, Leeds Beckett University, Leeds, UK
| |
Collapse
|
7
|
Guinot PG, Andrei S, Durand B, Martin A, Duclos V, Spitz A, Berthoud V, Constandache T, Grosjean S, Radhouani M, Anciaux JB, Nguyen M, Bouhemad B. Balanced Nonopioid General Anesthesia With Lidocaine Is Associated With Lower Postoperative Complications Compared With Balanced Opioid General Anesthesia With Sufentanil for Cardiac Surgery With Cardiopulmonary Bypass: A Propensity Matched Cohort Study. Anesth Analg 2023; 136:965-974. [PMID: 36763521 DOI: 10.1213/ane.0000000000006383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
BACKGROUND There are no data on the effect of balanced nonopioid general anesthesia with lidocaine in cardiac surgery with cardiopulmonary bypass. The main study objective was to evaluate the association between nonopioid general balanced anesthesia and the postoperative complications in relation to opioid side effects. METHODS Patients undergoing cardiac surgery with cardiopulmonary bypass between 2019 and 2021 were identified. After exclusion of patients for heart transplantation, left ventricular assistance device, and off-pump surgery, we classified patients according to an opioid general balanced anesthesia or a nonopioid balanced anesthesia with lidocaine. The primary outcome was a collapsed composite of postoperative complications that comprise respiratory failure and confusion, whereas secondary outcomes were acute renal injury, pneumoniae, death, intensive care unit (ICU), and hospital length of stay. RESULTS We identified 859 patients exposed to opioid-balanced general anesthesia with lidocaine and 913 patients exposed to nonopioid-balanced general anesthesia. Propensity score matching yielded 772 individuals in each group with balanced baseline covariates. Two hundred thirty-six patients (30.5%) of the nonopioid-balanced general anesthesia versus 186 patients (24.1%) presented postoperative composite complications. The balanced lidocaine nonopioid general anesthesia group was associated with a lower proportion with the postoperative complication composite outcome OR, 0.72 (95% CI, 0.58-0.92; P = .027). The number of patients with acute renal injury, death, and hospital length of stay did not differ between the 2 groups. CONCLUSIONS A balanced nonopioid general anesthesia protocol with lidocaine was associated with lower odds of postoperative complication composite outcome based on respiratory failure and confusion.
Collapse
Affiliation(s)
- Pierre-Grégoire Guinot
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
- Department of Anaesthesiology and Intensive Care Medicine, University of Burgundy and Franche-Comté, Dijon, France
| | - Stefan Andrei
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Bastien Durand
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Audrey Martin
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Valerian Duclos
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Alexandra Spitz
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Vivien Berthoud
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Tiberiu Constandache
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Sandrine Grosjean
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Mohamed Radhouani
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Jean-Baptiste Anciaux
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
| | - Maxime Nguyen
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
- Department of Anaesthesiology and Intensive Care Medicine, University of Burgundy and Franche-Comté, Dijon, France
| | - Belaid Bouhemad
- From the Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, Dijon, France
- Department of Anaesthesiology and Intensive Care Medicine, University of Burgundy and Franche-Comté, Dijon, France
| |
Collapse
|
8
|
Hinton L, Dumelow C, Hodgkinson J, Montgomery C, Martin A, Allen C, Tucker K, Green ME, Wilson H, McManus RJ, Chappell LC, Band R. 'Nesting networks': Women's experiences of social network support in high-risk pregnancy. Midwifery 2023; 120:103622. [PMID: 36893551 DOI: 10.1016/j.midw.2023.103622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 01/27/2023] [Accepted: 02/03/2023] [Indexed: 02/18/2023]
Abstract
OBJECTIVE Social support, an individual's social relationships (both online and offline), may provide protection against adverse mental health outcomes, such as anxiety and depression, which are high in women who have been hospitalised with high-risk pregnancy. This study explored the social support available to women at higher risk of preeclampsia during pregnancy by examining personal social networks. DESIGN Semi-structured interviews were accompanied by social network mapping using the web-based social networking tool GENIE. SETTING England. PARTICIPANTS Twenty-one women were recruited, of whom 18 were interviewed both during pregnancy and postnatally between April 2019 and April 2020. Nineteen women completed maps pre-natally, 17 women completed maps pre-natally and post-natally. Women were taking part in the BUMP study, a randomised clinical trial that included 2441 pregnant individuals at higher risk of preeclampsia and recruited at a mean of 20 weeks' gestation from 15 hospital maternity units in England between November 2018 and October 2019. RESULTS Women's social networks tightened during pregnancy. The inner network changed most dramatically postnatally with women reporting fewer network members. Interviews revealed networks were primarily 'real-life' rather than online social networks, with members providing emotional, informational, and practical support. Women with a high-risk pregnancy valued the relationships they developed with health professionals during pregnancy, and would like their midwife to have a more central role in their networks by providing informational and, where needed, emotional support. The social network mapping data supported the qualitative accounts of changing networks across high-risk pregnancy. CONCLUSION Women with a high-risk pregnancy seek to build "nesting networks" to support them through pregnancy into motherhood. Different types of support are sought from trusted sources. Midwives can play a key role. PRACTICE IMPLICATIONS As well as highlighting other potential needs during pregnancy and the ways in which they can be met, support from midwives has a key role. Through talking to women early in their pregnancy, signposting information and explaining ways to contact health professionals regarding informational or emotional support would fill a gap that currently is met by other aspects of their network.
Collapse
Affiliation(s)
- L Hinton
- The Healthcare Improvement Studies (THIS) Institute, University of Cambridge.
| | - C Dumelow
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
| | - J Hodgkinson
- Institute of Applied Health Research, University of Birmingham, Birmingham
| | - C Montgomery
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
| | - A Martin
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
| | - C Allen
- School of Health Sciences, University of Southampton, Southampton, UK. SO17 1BJ
| | - K Tucker
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
| | | | - H Wilson
- Department of Women and Children's Health, King's College London, London
| | - R J McManus
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
| | - L C Chappell
- Department of Women and Children's Health, King's College London, London
| | - R Band
- School of Health Sciences, University of Southampton, Southampton, UK. SO17 1BJ
| |
Collapse
|
9
|
Guinot PG, Durand B, Besnier E, Mertes PM, Bernard C, Nguyen M, Berthoud V, Abou-Arab O, Bouhemad B, Martin A, Duclos V, Spitz A, Constandache T, Grosjean S, Radhouani M, Anciaux JB, Missaoui A, Morgant MC, Bouchot O, Jazayeri S, Demailly Z, Huette P, Guilbart M, Besserve P, Beyls C, Dupont H, Kindo M, Wpiff T. Epidemiology, risk factors and outcomes of norepinephrine use in cardiac surgery with cardiopulmonary bypass: a multicentric prospective study. Anaesth Crit Care Pain Med 2023; 42:101200. [PMID: 36758855 DOI: 10.1016/j.accpm.2023.101200] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Revised: 01/27/2023] [Accepted: 01/27/2023] [Indexed: 02/10/2023]
Abstract
BACKGROUND The present study was designed to describe the prevalence of norepinephrine use, the factors associated with its use, and the incidence of postoperative complications according to norepinephrine use, in patients undergoing cardiac surgery with cardiopulmonary bypass. METHOD We performed a prospective, multicenter, observational study in 4 University-affiliated medico-surgical cardiovascular units. We analyzed all patients treated with cardiac surgery after excluding pre-ECMO surgery, LVAD implantation, heart transplantation and intra-operative hemorrhage. RESULTS Of 9316 patients screened during the study period, 2862 were included and 2510 were analyzed. Among them, 1549 (61%) were treated with norepinephrine with a median maximal dose of 0.11 [0.06-0.2] μg.kg-1.min-1 and a median duration of 10 h [2-24]. Norepinephrine was most often started in the operating room before cardiopulmonary bypass. The multiple regression logistic analysis identified several modifiable (haematocrit, maintenance of beta-blocker, cardiopulmonary bypass time, glucose-insulin-potassium, Custodiol cardioplegia, Delnido cardioplegia, and fibrinogen transfusion) and non-modifiable factors (age, ASA score, chronic high blood pressure, coronary disease, dyslipidemia, right ventricular dysfunction, left ventricular dysfunction, active endocarditis, and valvular aortic surgery) associated with norepinephrine use. Mortality, morbidity (neurological and renal complications, death) and length of stay in the ICU were higher in patients treated with norepinephrine. CONCLUSION Norepinephrine is often used in cardiac surgical patients but for <24 h with a low dose. Many preoperative and surgical factors are associated with norepinephrine use. Patients supported by norepinephrine have a higher incidence of major postoperative events.
Collapse
Affiliation(s)
- Pierre-Grégoire Guinot
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France; University of Burgundy and Franche-Comté, LNC UMR1231, F-21000 Dijon, France.
| | - Bastien Durand
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Emmanuel Besnier
- Department of Anaesthesiology and Critical Care Medicine, Rouen University Medical Centre, 76000 Rouen, France
| | - Paul-Michel Mertes
- Department of Anaesthesiology and Critical Care Medicine, Strasbourg University Medical Centre, Strasbourg, France
| | - Chloe Bernard
- Department of Cardiac Surgery, Dijon University Medical Centre, 21000 Dijon, France
| | - Maxime Nguyen
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France; University of Burgundy and Franche-Comté, LNC UMR1231, F-21000 Dijon, France
| | - Vivien Berthoud
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Osama Abou-Arab
- Department of Anaesthesiology and Critical Care Medicine, Amiens University Medical Centre, 80000 Amiens, France
| | - Belaid Bouhemad
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France; University of Burgundy and Franche-Comté, LNC UMR1231, F-21000 Dijon, France
| | - Audrey Martin
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Valerian Duclos
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Alexandra Spitz
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Tiberiu Constandache
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Sandrine Grosjean
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Mohamed Radhouani
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Jean-Baptiste Anciaux
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Anis Missaoui
- Department of Anaesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France
| | - Marie-Catherine Morgant
- Department of Anaesthesiology and Critical Care Medicine, Rouen University Medical Centre, 76000 Rouen, France
| | - Olivier Bouchot
- Department of Anaesthesiology and Critical Care Medicine, Rouen University Medical Centre, 76000 Rouen, France
| | - Saed Jazayeri
- Department of Anaesthesiology and Critical Care Medicine, Rouen University Medical Centre, 76000 Rouen, France
| | - Zoe Demailly
- Department of Anaesthesiology and Critical Care Medicine, Rouen University Medical Centre, 76000 Rouen, France
| | - Pierre Huette
- Department of Anaesthesiology and Critical Care Medicine, Strasbourg University Medical Centre, Strasbourg, France
| | - Mathieu Guilbart
- Department of Anaesthesiology and Critical Care Medicine, Strasbourg University Medical Centre, Strasbourg, France
| | - Patricia Besserve
- Department of Anaesthesiology and Critical Care Medicine, Strasbourg University Medical Centre, Strasbourg, France
| | - Christophe Beyls
- Department of Anaesthesiology and Critical Care Medicine, Strasbourg University Medical Centre, Strasbourg, France
| | - Hervé Dupont
- Department of Cardiovascular Surgery, University Hospitals of Strasbourg, Strasbourg, France
| | - Michel Kindo
- Department of Cardiovascular Surgery, University Hospitals of Strasbourg, Strasbourg, France
| | - Thibaut Wpiff
- Department of Cardiac Surgery, Dijon University Medical Centre, 21000 Dijon, France
| |
Collapse
|
10
|
Peña M, Martin A, Holland P, Black LE, Peterman J, Montoya-Williams D, Burris H, Ciara N, Wooten J, Christ L, Walker W, Lilley J, Tkacs M, Scott L. Qualitative analysis of black birthing parents’ influences on infant feeding. Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00554-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
11
|
Olié V, Lailler G, Bejot Y, Martin A, Gabet A, Grave C, Regnault N, Chatignoux E, Kretz S, Tsatsaris V, Plu Bureau G, Deneux-Tharaux C, Blacher J. Cardiovascular diseases in pregnancy: Incidence, temporal trends and characteristics of women, the nationwide CONCEPTION study. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
12
|
Prykhodko Y, Martin A, Oulyadi H, Marais S, Fatyeyeva K. Polymer EVA-OH membrane with improved water/gas separation performance: Influence of VAc/VOH repeating units ratio on membrane physical chemical properties. J Memb Sci 2023. [DOI: 10.1016/j.memsci.2023.121386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
13
|
Martin A, Mercader A, Dominguez F, Quiñonero A, Perez M, Gonzalez-Martin R, Delgado A, Mifsud A, Pellicer A, De Los Santos MJ. Mosaic results after preimplantation genetic testing for aneuploidy may be accompanied by changes in global gene expression. Front Mol Biosci 2023; 10:1180689. [PMID: 37122560 PMCID: PMC10140421 DOI: 10.3389/fmolb.2023.1180689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 04/04/2023] [Indexed: 05/02/2023] Open
Abstract
Aneuploidy in preimplantation embryos is a major cause of human reproductive failure. Unlike uniformly aneuploid embryos, embryos diagnosed as diploid-aneuploid mosaics after preimplantation genetic testing for aneuploidy (PGT-A) can develop into healthy infants. However, the reason why these embryos achieve full reproductive competence needs further research. Current RNA sequencing techniques allow for the investigation of the human preimplantation transcriptome, providing new insights into the molecular mechanisms of embryo development. In this prospective study, using euploid embryo gene expression as a control, we compared the transcriptome profiles of inner cell mass and trophectoderm samples from blastocysts with different levels of chromosomal mosaicism. A total of 25 samples were analyzed from 14 blastocysts with previous PGT-A diagnosis, including five low-level mosaic embryos and four high-level mosaic embryos. Global gene expression profiles visualized in cluster heatmaps were correlated with the original PGT-A diagnosis. In addition, gene expression distance based on the number of differentially expressed genes increased with the mosaic level, compared to euploid controls. Pathways involving apoptosis, mitosis, protein degradation, metabolism, and mitochondrial energy production were among the most deregulated within mosaic embryos. Retrospective analysis of the duration of blastomere cell cycles in mosaic embryos revealed several mitotic delays compared to euploid controls, providing additional evidence of the mosaic status. Overall, these findings suggest that embryos with mosaic results are not simply a misdiagnosis by-product, but may also have a genuine molecular identity that is compatible with their reproductive potential.
Collapse
Affiliation(s)
- A. Martin
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
| | - A. Mercader
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
- IVI-RMA Valencia, Valencia, Spain
| | - F. Dominguez
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
| | - A. Quiñonero
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
| | - M. Perez
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
| | | | | | | | - A. Pellicer
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
- IVI-RMA Rome, Rome, Italy
| | - M. J. De Los Santos
- IVI-RMA Foundation, Health Research Institute La Fe, Valencia, Spain
- IVI-RMA Valencia, Valencia, Spain
- *Correspondence: M. J. De Los Santos,
| |
Collapse
|
14
|
Lai K, Li V, Fonseca E, Ding H, Chen L, Xia K, Martin A, Schelfhout J. PREVALENCE AND BURDEN OF CHRONIC COUGH IN CHINA: RESULTS FROM A POPULATION-BASED SURVEY. Ann Allergy Asthma Immunol 2022. [DOI: 10.1016/j.anai.2022.08.725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
15
|
Elhalawani H, Hammoudeh L, Cagney D, Qian J, Martin A, Zgrabik J, Meyers J, Pataki K, Martin K, Khouj Y, Verry C, Bi W, Arnaout O, Christ S, Alexander B, Tanguturi S, Rahman R, Haas-Kogan D, Aizer A. Leveraging Serial MRI Radiomics and Machine Learning to Predict Risk of Radiation Necrosis in Patients with Brain Metastases Managed with Stereotactic Radiation and Immunotherapy. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
16
|
Ragab I, O'Brien M, Martin A. 167 ASSISTED DECISION-MAKING (CAPACITY) ACT 2015: KNOWLEDGE AND ATTITUDES AMONG HOSPITAL DOCTORS. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Assessing capacity is part of our daily practice, and an important pillar of patient centred care. Assisted Decision-Making (Capacity) Act 2015, which is due to commence in June 2022, is an act to provide reform of the law to assist patients who require help in making decisions in a manner that will ensure their autonomy, dignity, and best interests. This study aimed to investigate the knowledge, attitudes, and confidence of hospital doctors regarding this act.
Methods
This study was conducted using an anonymous online survey completed by hospital doctors from all levels and specialties in a tertiary hospital. The survey contained two sections, the first asked questions on confidence and attitudes about capacity assessment. The second section contained practical scenarios to test knowledge around the new framework for decision support under the Act.
Results
Of the 670 consultants and non-consultant hospital doctors (NCHD) surveyed, an 11% response rate was achieved (75 respondents), 44% were consultants 56% were NCHD. 43% reported to lack confidence in assessing capacity. 92% felt that they needed more training regarding the act. Also, 80% agreed the act will have an impact on our practice. 80% thought capacity was carried out by a certain specialty (mostly Psychiatry and Geriatrics). In the decision support scenarios 18-27% of responders felt they did not know what the appropriate level of decision support was. In each scenario, with the exception of one, the most frequent response was the correct one but responses were widely distributed on most questions.
Conclusion
Despite the lack of a representative sample, doctors’ knowledge about capacity seems to have improved compared to previously carried out studies. However, our study appears to indicate a significant knowledge gap and further training is needed regarding the Assisted Decision-Making (Capacity) Act 2015 proposed to commence next month. Mandatory training on the act should be considered by HSE and the professional training bodies.
Collapse
Affiliation(s)
- I Ragab
- Beaumont Hospital , Dublin, Ireland
| | | | - A Martin
- Beaumont Hospital , Dublin, Ireland
| |
Collapse
|
17
|
Roche N, Aggarwal B, Boucot I, Mittal L, Martin A, Chrystyn H. The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review. Respir Med 2022; 202:106949. [PMID: 36063773 DOI: 10.1016/j.rmed.2022.106949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/28/2022] [Accepted: 08/01/2022] [Indexed: 11/19/2022]
Abstract
BACKGROUND Many patients with asthma use their inhalers incorrectly, which can lead to sub-optimal asthma control and an increased risk of exacerbations. The Accuhaler/Diskus and Turbuhaler are arguably two of the most commonly used dry powder inhalers worldwide. METHODS A systematic literature review (SLR) was conducted to assess the impact of inhalation errors with these dry powder inhalers on clinical outcomes in asthma. Database searches were conducted in MEDLINE, Embase and proceedings from scientific conferences. Observational studies in adults and adolescents with asthma, reporting data for Accuhaler/Diskus and Turbuhaler devices and at least one outcome of interest, were included. Dual-independent screening and validation of studies was performed. RESULTS The search identified 35 studies. A range of inhaler errors was observed across studies and devices. In 8 out of the 9 studies that involved the two devices, the percentage of overall inhaler error rates was numerically (7 studies) or significantly (1 study) higher for Turbuhaler than Diskus, ranging from 3.7% to 71.9% for Diskus and 1.2%-83% for Turbuhaler. Critical errors, reported in three studies using similar definitions, ranged from 20% to 43% for Diskus and 32%-100% for Turbuhaler. Five studies reported a significant association between inhaler errors and worse asthma control, while one showed no difference. CONCLUSIONS This SLR identified a large range of inhaler errors with both devices. Across devices, a better inhalation technique was associated with better asthma outcomes. This systematic review confirms the importance of patients using their inhalers correctly as an integral part of achieving optimal asthma outcomes.
Collapse
Affiliation(s)
- N Roche
- Hôpital Cochin, AP-HP. Centre-Université de Paris, Paris, France.
| | | | | | | | | | | |
Collapse
|
18
|
Marcellin F, Brégigeon-Ronot S, Ramier C, Protopopescu C, Gilbert C, Di Beo V, Duvivier C, Bureau-Stoltmann M, Rosenthal E, Wittkop L, Salmon-Céron D, Carrieri P, Sogni P, Barré T, Salmon D, Wittkop L, Sogni P, Esterle L, Trimoulet P, Izopet J, Serfaty L, Paradis V, Spire B, Carrieri P, Valantin M, Pialoux G, Chas J, Zaegel-Faucher O, Barange K, Naqvi A, Rosenthal E, Bicart-See A, Bouchaud O, Gervais A, Lascoux-Combe C, Goujard C, Lacombe K, Duvivier C, Neau D, Morlat P, Bani-Sadr F, Meyer L, Boufassa F, Autran B, Roque A, Solas C, Fontaine H, Costagliola D, Piroth L, Simon A, Zucman D, Boué F, Miailhes P, Billaud E, Aumaître H, Rey D, Peytavin G, Petrov-Sanchez V, Levier A, Salmon D, Usubillaga R, Sogni P, Terris B, Tremeaux P, Katlama C, Valantin M, Stitou H, Simon A, Cacoub P, Nafissa S, Benhamou Y, Charlotte F, Fourati S, Poizot-Martin I, Zaegel O, Laroche H, Tamalet C, Pialoux G, Chas J, Callard P, Bendjaballah F, Amiel C, Le Pendeven C, Marchou B, Alric L, Barange K, Metivier S, Selves J, Larroquette F, Rosenthal E, Naqvi A, Rio V, Haudebourg J, Saint-Paul M, De Monte A, Giordanengo V, Partouche C, Bouchaud O, Martin A, Ziol M, Baazia Y, Iwaka-Bande V, Gerber A, Uzan M, Bicart-See A, Garipuy D, Ferro-Collados M, Selves J, Nicot F, Gervais A, Yazdanpanah Y, Adle-Biassette H, Alexandre G, Peytavin G, Lascoux-Combe C, Molina J, Bertheau P, Chaix M, Delaugerre C, Maylin S, Lacombe K, Bottero J, Krause J, Girard P, Wendum D, Cervera P, Adam J, Viala C, Vittecocq D, Goujard C, Quertainmont Y, Teicher E, Pallier C, Lortholary O, Duvivier C, Rouzaud C, Lourenco J, Touam F, Louisin C, Avettand-Fenoel V, Gardiennet E, Mélard A, Neau D, Ochoa A, Blanchard E, Castet-Lafarie S, Cazanave C, Malvy D, Dupon M, Dutronc H, Dauchy F, Lacaze-Buzy L, Desclaux A, Bioulac-Sage P, Trimoulet P, Reigadas S, Morlat P, Lacoste D, Bonnet F, Bernard N, Hessamfar M, Paccalin J, Martell C, Pertusa M, Vandenhende M, Mercié P, Malvy D, Pistone T, Receveur M, Méchain M, Duffau P, Rivoisy C, Faure I, Caldato S, Bioulac-Sage P, Trimoulet P, Reigadas S, Bellecave P, Tumiotto C, Pellegrin J, Viallard J, Lazzaro E, Greib C, Bioulac-Sage P, Trimoulet P, Reigadas S, Zucman D, Majerholc C, Brollo M, Farfour E, Boué F, Polo Devoto J, Kansau I, Chambrin V, Pignon C, Berroukeche L, Fior R, Martinez V, Abgrall S, Favier M, Deback C, Lévy Y, Dominguez S, Lelièvre J, Lascaux A, Melica G, Billaud E, Raffi F, Allavena C, Reliquet V, Boutoille D, Biron C, Lefebvre M, Hall N, Bouchez S, Rodallec A, Le Guen L, Hemon C, Miailhes P, Peyramond D, Chidiac C, Ader F, Biron F, Boibieux A, Cotte L, Ferry T, Perpoint T, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Amiri M, Valour F, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Augustin-Normand C, Scholtes C, Le-Thi T, Piroth L, Chavanet P, Duong Van Huyen M, Buisson M, Waldner-Combernoux A, Mahy S, Salmon Rousseau A, Martins C, Aumaître H, Galim S, Bani-Sadr F, Lambert D, Nguyen Y, Berger J, Hentzien M, Brodard V, Rey D, Partisani M, Batard M, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Fischer P, Gantner et S Fafi-Kremer P, Roustant F, Platterier P, Kmiec I, Traore L, Lepuil S, Parlier S, Sicart-Payssan V, Bedel E, Anriamiandrisoa S, Pomes C, Touam F, Louisin C, Mole M, Bolliot C, Catalan P, Mebarki M, Adda-Lievin A, Thilbaut P, Ousidhoum Y, Makhoukhi F, Braik O, Bayoud R, Gatey C, Pietri M, Le Baut V, Ben Rayana R, Bornarel D, Chesnel C, Beniken D, Pauchard M, Akel S, Caldato S, Lions C, Ivanova A, Ritleg AS, Debreux C, Chalal L, J.Zelie, Hue H, Soria A, Cavellec M, Breau S, Joulie A, Fisher P, Gohier S, Croisier-Bertin D, Ogoudjobi S, Brochier C, Thoirain-Galvan V, Le Cam M, Carrieri P, Chalouni M, Conte V, Dequae-Merchadou L, Desvallées M, Esterle L, Gilbert C, Gillet S, Guillochon Q, Khan C, Knight R, Marcellin F, Michel L, Mora M, Protopopescu C, Roux P, Spire B, Barré T, Ramier C, Sow A, Lions C, Di Beo V, Bureau M, Wittkop L. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH). JHEP Rep 2022; 5:100614. [DOI: 10.1016/j.jhepr.2022.100614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 10/06/2022] [Accepted: 10/07/2022] [Indexed: 11/06/2022] Open
|
19
|
Patalano KK, Martin A. Telehealth’s Impact on Chronic Disease Management Through Delivery of Medical Nutrition Therapy. J Acad Nutr Diet 2022. [DOI: 10.1016/j.jand.2022.08.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
20
|
Walker C, Weekes D, Torga G, Quist J, Trendell J, Hitchens L, Martin A, Davidson K, Kollarovic G, Grigoriadis A, Pines J, Pettitt S, Lord C, Tutt A. HORMAD1 drives spindle assembly checkpoint defects and sensitivity to multiple mitotic kinases. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00980-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Hutter V, Hoffman E, Martin A. LP-21 ImmuLUNG: An immune-centric approach to demonstrating how human in vitro co-culture systems can inform mechanistic-driven inhalation safety assessment. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
22
|
Gallien Y, Martin A, Thiam MM, Caserio-Schonemann C, Strat YL. 93 - Passages aux urgences pour usage des opioïdes de 2010 à 2018 en France métropolitaine. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.06.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
23
|
Oulee A, Ahn S, Shahsavari S, Martin A, Wu J. LB897 The risk of COVID-19 infection in patients with alopecia areata. J Invest Dermatol 2022. [PMCID: PMC9296966 DOI: 10.1016/j.jid.2022.05.915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
24
|
Pardiñas Garcia M, De los Santos J, Viloria T, Ortega-Jaen D, Martin A, De los Santos M. P-082 Microfluidic-based device selects sperm with less DNA damage and higher motility, what else? Hum Reprod 2022. [DOI: 10.1093/humrep/deac107.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Does the microfluidic-based sperm selection device ZyMōt improve sperm parameters and other laboratory key performance indicator (KPI) values compared to the conventional swim-up method?
Summary answer
The microfluidic-based sperm selection device ZyMōt selects sperm with lower DNA fragmentation and higher motility than conventional swim-up method in intracytoplasmic sperm injection (ICSI) cycles.
What is known already
Elevated levels of sperm DNA fragmentation (SDF) in semen samples have been associated with poor embryo development and low pregnancy rates. SDF refers to breaks in the sperm's genetic material, mainly due to defects during spermatogenesis and other factors such as reactive oxygen species that are favored by centrifugation. Conventional sperm selection methods, by integrating centrifugation into their protocols, have become ineffective in selecting sperm with low SDF. In order to solve this problem and improve reproductive outcomes, microfluidic-based devices such as ZyMōt have been designed to avoid centrifugation and select spermatozoa with low SDF.
Study design, size, duration
Prospective, experimental, single-center study conducted from June to December 2021. A total of 14 couples with ≥ 10 retrieved oocytes were recruited for an intra-patient comparison. Semen sample was split and processed for ICSI by the conventional swim-up method or by the microfluidic-based device ZyMōt. Each fraction was used to fertilize half of the total number of oocytes retrieved. SDF index, semen parameters, useful blastocyst rate, fertilization rate and morphokinetic variables were observed.
Participants/materials, setting, methods
Oocytes retrieved were from own (n = 96) and donation cycles (n = 93). From each patient, the cohort of oocytes was divided into two groups: 1) inseminated with spermatozoa selected by swim-up and 2) inseminated with spermatozoa selected by ZyMōt 850 µL device. Embryo evaluation and development were then followed by time-lapse monitoring using EmbryoScope. Sperm chromatin dispersion (SCD) assay was used to measure SDF, analyzed by ImageJ. Each treatment followed routine protocol established in the clinical practice.
Main results and the role of chance
SDF index was significantly lower in ZyMōt group in comparison with swim-up group (10% vs 20%), indicating a better selection by the ZyMōt of sperm with less DNA breaks. Additionally, ZyMōt group also presented a significantly greater number of spermatozoa with progressive motility (96.9% vs 95.4%). In contrast, useful blastocyst rate showed a slightly, but not significantly, increment in ZyMōt group compared to swim-up group (53.2% vs 46.6%). No significant differences in fertilization rate or sperm recovery rate were observed between groups. Regarding morphokinetic parameters, timing variables from first cell division to blastocyst stage (t2-tB) showed no significant correlation with ZyMōt group contrasted with swim-up. Blastocysts were evaluated and a value was assigned with respect to their quality (A to D). There was a higher number of embryos with A grade in ZyMōt group and a higher number of embryos with D grade in swim-up group. The annotated variables were assessed using paired t-test and P value <0.05 was considered statistically significant.
Limitations, reasons for caution
The impact on reproductive outcomes may vary depending on whether the breakage is single- or double-stranded, however, SCD is not able to distinguish between them. These, together with the oocyte's ability to repair sperm damage, lead us to the explanation for the non-significance on embryo quality.
Wider implications of the findings
This study provides further insights into the use of ZyMōt for the selection of low SDF spermatozoa in a simple manner. Its use could be indicated in patients with a high SDF value in their semen samples. Benefits on reproductive outcome will be confirmed with larger sample size.
Trial registration number
2102-VLC-007-MD
Collapse
Affiliation(s)
| | | | - T Viloria
- IVIRMA Valencia, IVF Laboratory , Valencia, Spain
| | - D Ortega-Jaen
- IVI Foundation-IIS La Fe, Research and Innovation , Valencia, Spain
| | - A Martin
- IVI Foundation-IIS La Fe, Research and Innovation , Valencia, Spain
| | | |
Collapse
|
25
|
Trujillo I, Feliu A, Palahi M, Martin A, Moret R, Cotán D, Sandalinas M. O-145 Limitations of designing carrier screening panels based on estimated frequencies. Concordance between recommendations and observed frequencies. Hum Reprod 2022. [DOI: 10.1093/humrep/deac105.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Are recommended carrier screening (CS) panels suitable worldwide or should they be designed taking into account observed carrier frequencies (CF)?
Summary answer
Limitations of carrier screening panel recommendations based on estimated frequencies could be avoided with a worldwide-database of observed carrier frequencies.
What is known already
Currently, there is no consensus for specific gene panel for CS, but some scientific societies, based on estimated carrier frequencies, recommend to analyze a narrow panel rather than exome. The American College of Medical Genetics and Genomics (ACMG) recently recommended a 4-tiered system, encouraging to analyze genes in tier 3, genes with less carrier frequency (tier 4) are only recommended to be analyzed on specific cases. Similarly, Sociedad Española de Fertilidad (SEF) recommends in absence of genetic matching (GM) a 6 gene basic panel for donor screening and in a GM context suggests a 50-diseases panel.
Study design, size, duration
This study includes 8542 patients analyzed with an expanded carrier screening panel of 300 genes, including autosomal recessive (AR) and X-linked (XL) disorders by next-generation sequencing (NGS). ACMG guidelines were followed for variant interpretation and only pathogenic and likely pathogenic variants were reported. The study has been conducted between August 2018 and December 2021.
Participants/materials, setting, methods
DNA was extracted and sequenced. Obtained data was processed by bioinformatic tools. CF for diseases analyzed was stablished. Genes were categorized according to tier-3 of the ACMG recommendations (112 genes, only 80 included on this study) and also by 50-disease panel of SEF recommendations (49 genes, 40 included on this study). Likewise, analyzed diseases were divided in two groups according to the obtained CF: A (CF ≤ 1/200 - 56 genes); B (CF > 1/200 - 244 genes).
Main results and the role of chance
The analysis of the 8542 patients showed that 2582 (30.23%) of them were not carriers of any disease analyzed, 2205 (25.81%) of them were only carriers of one or more of the diseases included in the ACMG tier3 panel and 3755 (43.96%) were carriers of at least one disease not included this category.
When diseases analyzed were categorized by SEF 50-disease panel, 2280 (26.69%) patients were only carriers of one or more of the diseases included in this panel and 3680 (43.08%) were carriers of at least one disease that would not be analyzed by this panel.
On the other hand, when diseases were divided by observed carrier frequency, a total of 3476 patients (40.69%) were carriers only of a disease(s) included in A group. With this panel, only 2484 (29.08%) of the 8542 patients would not have been correctly diagnosed. Moreover, the variants undetected would affect less frequent diseases (B group).
It is important to notice that group A has been created regarding the data of a 300 gene panel. If another panel would have been analyzed, the group of genes may have changed, but the data collected highlights the importance of observed CF on panel design.
Limitations, reasons for caution
Not all Tier3 ACMG and 50-disease SEF genes are included due to original panel limitations. Observed CF may vary depending on the population analyzed. NGS panel design does not cover variants in regulatory or deep intronic regions. Pseudogenes can interfere. Not all structural variants can be detected by NGS.
Wider implications of the findings
These data highlight the importance of reviewing the genes included in carrier screening panels by their frequency. Furthermore, it points out the need to have updated databases with observed CF available so an universal panel can be designed or adapted to patient’s needs.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- I Trujillo
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - A Feliu
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - M Palahi
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - A Martin
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - R Moret
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - D Cotán
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| | - M Sandalinas
- FullGenomics S.L., NGS Laboratory , Barcelona, Spain
| |
Collapse
|
26
|
Martin A, Konac D, Maughan B, Barker E. Mother and father depression symptoms and child emotional difficulties: a network model. Eur Psychiatry 2022. [PMCID: PMC9566781 DOI: 10.1192/j.eurpsy.2022.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction Enhancing understanding of depression symptom interactions between parents and associations with subsequent child emotional difficulties will inform targeted treatment of depression to prevent transmission within families. Objectives To use a network approach to identify ‘bridge’ symptoms that reinforce mother and father depression, and whether bridge symptoms, as well as other symptoms, impact subsequent child emotional difficulties. Methods Symptoms were examined using two unregularized partial correlation network models. The study included 4,492 mother-father-child trios from a prospective, population-based cohort in the United Kingdom. Mother and father reports of depression symptoms were assessed when the child was twenty-one months old. Child emotional difficulties were reported by the mother at ages nine, eleven and thirteen years. Results Bridge symptoms mutually reinforcing mother and father depression symptoms were feelings of guilt and self-harm ideation, whereas anhedonia acted as a bridge from the father to the mother, but not vice-versa (fig.1, network 1). The symptom of feelings of guilt in mothers was the only bridge symptom which directly associated with child emotional difficulties. Other symptoms that directly associated with child emotional difficulties were feeling overwhelmed for fathers and anhedonia, sadness, and panic in mothers (fig.1, network 2). ![]()
Conclusions Specific symptom interactions are central to the co-occurrence of depression symptoms between parents. Of interest, only one of the bridge symptoms associated with later child emotional difficulties. In addition, specific symptom-to-child outcomes were identified, suggesting that different symptoms in mothers and fathers are central for increased vulnerability in children. Disclosure No significant relationships.
Collapse
|
27
|
Johnstone A, McCrorie P, Cordovil R, Fjørtoft I, Iivonen S, Jidovtseff B, Lopes F, Reilly JJ, Thomson H, Wells V, Martin A. Nature-Based Early Childhood Education and Children's Physical Activity, Sedentary Behavior, Motor Competence, and Other Physical Health Outcomes: A Mixed-Methods Systematic Review. J Phys Act Health 2022; 19:456-472. [PMID: 35537707 PMCID: PMC7613039 DOI: 10.1123/jpah.2021-0760] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 03/04/2022] [Accepted: 04/03/2022] [Indexed: 11/18/2022]
Abstract
BACKGROUND The purpose was to synthesize evidence on the association between nature-based Early Childhood Education (ECE) and children's physical activity (PA) and motor competence (MC). METHODS A literature search of 9 databases was concluded in August 2020. Studies were eligible if (1) children were aged 2-7 years old and attending ECE, (2) ECE settings integrated nature, and (3) assessed physical outcomes. Two reviewers independently screened full-text articles and assessed study quality. Synthesis was conducted using effect direction (quantitative), thematic analysis (qualitative), and combined using a results-based convergent synthesis. RESULTS 1370 full-text articles were screened and 39 (31 quantitative and 8 qualitative) studies were eligible; 20 quantitative studies assessed PA and 6 assessed MC. Findings indicated inconsistent associations between nature-based ECE and increased moderate to vigorous PA, and improved speed/agility and object control skills. There were positive associations between nature-based ECE and reduced sedentary time and improved balance. From the qualitative analysis, nature-based ECE affords higher intensity PA and risky play, which could improve some MC domains. The quality of 28/31 studies was weak. CONCLUSIONS More controlled experimental designs that describe the dose and quality of nature are needed to better inform the effectiveness of nature-based ECE on PA and MC.
Collapse
Affiliation(s)
- A Johnstone
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, Glasgow G3 7HR, UK
| | - P McCrorie
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, Glasgow G3 7HR, UK
| | - R Cordovil
- CIPER, Faculty of Human Kinetics, University of Lisbon, Estrada da Costa, 1499-002 Cruz Quebrada, Lisboa, Portugal
| | - I Fjørtoft
- Faculty of Humanities, Sports and Education Sciences, University of South-Eastern Norway, Lærerskoleveien 40, 3679 Notodden, Norway
| | - S Iivonen
- School of Applied Educational Science and Teacher Education, University of Eastern Finland, Yliopistokatu 2, FI-80100 Joensuu, Finland
| | - B Jidovtseff
- Research Unit on Childhood, Department of Sport and Rehabilitation Sciences, University of Liege, 2 Allee des sports, 4000 Liege, Belgium
| | - F Lopes
- Laboratory of Motor Behavior, Faculty of Human Kinetics, University of Lisbon, Estrada da Costa, Cruz-Quebrada, 1499-002 Portugal
| | - JJ Reilly
- School of Psychological Sciences and Health, University of Strathclyde, 50 George Street, Glasgow G1 1QE, UK
| | - H Thomson
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, Glasgow G3 7HR, UK
| | - V Wells
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, Glasgow G3 7HR, UK
| | - A Martin
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, Glasgow G3 7HR, UK
| |
Collapse
|
28
|
Ryan GA, Finnegan C, McAuliffe FM, Malone FD, Müllers SM, Corcoran S, Mulcahy C, Dalrymple J, Donnelly J, Walsh J, Mcparland P, Martin A, Carroll S, Kent E. Fetoscopic Laser Ablation for Twin-to-Twin Transfusion Syndrome: A 15-year Review of Perinatal Survival. Ir Med J 2022; 115:595. [PMID: 35696199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective Twin to twin transfusion syndrome (TTTS) complicates 5-15% of monochorionic twin pregnancies and untreated is associated with a 90% mortality rate. The aim was to present the perinatal survival of patients with TTTS treated with laser ablation, by a national fetal medicine team. Methods This was a review of all cases of TTTS treated with fetoscopic laser ablation performed from March 2006 through to December 2020. All patients treated with fetoscopic laser were identified from the hospital database. The perinatal outcomes for the overall cohort and the individual Quintero stages were determined. Results A total of 155 cases of TTTS underwent fetoscopic laser ablation during the study period. The median gestational age at diagnosis was 19+1 weeks, with a mean growth discordance of 23.6%. The Quintero stage at diagnosis was: Stage 1 6.5% (10/155), Stage 2 49% (76/155), Stage 3 38.7% (60/155), Stage 4 5.8% (9/155). There was at least one survivor in 83.2% (129/155) of pregnancies, with dual survival in 52.9% (82/155). An increase in the rate of any survivor was observed from 75% (2006-2014) to 94% (2014-2020) (p<0.05). Dual survival decreased with increasing Quintero Stage (p<0.05). 80.6% (125/155) of pregnancies delivered prior to 34+6 weeks gestation. Conclusion Fetoscopic laser ablation is the recommended first line treatment for severe TTTS. We observed a survival rate of at least one twin in 83.2% pregnancies which is comparable to internationally published data on single-centre outcomes.
Collapse
Affiliation(s)
- G A Ryan
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
- UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
| | - C Finnegan
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
- Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
| | - F M McAuliffe
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
- UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
| | - F D Malone
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
- Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
| | - S M Müllers
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
| | - S Corcoran
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
- UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
| | - C Mulcahy
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
| | - J Dalrymple
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
| | - J Donnelly
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
- UCD Obstetrics & Gynaecology, University College Dublin, Ireland
| | - J Walsh
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
- UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
| | - P Mcparland
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
- UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
| | - A Martin
- UCD Obstetrics & Gynaecology, University College Dublin, Ireland
- Department of Obstetrics and Gynaecology, The Coombe Women And Infants University Hospital, Dublin, Ireland
| | - S Carroll
- Department of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland
| | - E Kent
- Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland
| |
Collapse
|
29
|
Connolly CE, Norris K, Martin A, Dawkins S, Meehan C. A taxonomy of occupational and organisational stressors and protectors of mental health reported by veterinary professionals in Australasia. Aust Vet J 2022; 100:367-376. [PMID: 35560212 PMCID: PMC9544948 DOI: 10.1111/avj.13167] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Revised: 04/21/2022] [Accepted: 04/25/2022] [Indexed: 11/29/2022]
Abstract
AIM To develop a taxonomy of positive and negative occupational and organisational factors reported that impact the mental health of veterinary professionals. METHODS Veterinary professionals working in Australasia were surveyed between February and June of 2021. The survey comprised two questions related to participants' perceptions of the positive and negative aspects of their job role that impact their mental health and wellbeing. Reflexive thematic analysis was employed to analyse the responses and generate two taxonomies of occupational and organisation stressors and protectors reported by participants. RESULTS Fifty-three responses from veterinary professionals were analysed. The final stressor taxonomy generated contained 9 overarching themes and 36 subthemes. The most common of these were negative work conditions, challenging relationships with clients, and adverse events and patient outcomes. The taxonomy of protectors contained 11 overarching themes and 32 subthemes, with the most common including fulfillment and satisfaction, positive work conditions, and relationships with colleagues. CONCLUSION This study is the first to examine both positive and negative factors in the veterinary industry reported by veterinary professionals in Australasia. The results highlighted stressors that can be addressed on both an individual and organisational level to promote the mental and health well-being of professionals working in the animal care industry.
Collapse
Affiliation(s)
- C E Connolly
- School of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia
| | - K Norris
- School of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia
| | - A Martin
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
| | - S Dawkins
- School of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia
| | - C Meehan
- School of Psychological Sciences, University of Tasmania, Hobart, Tasmania, Australia
| |
Collapse
|
30
|
Martin A, Carignan D, Beaudry M, Ménard É, Foster W, Vigneault É, Magnan S, Lachance B, Poulin É, Lacroix F, Archambault L, Beaulieu L, Després P. PD-0579 Ultra-hypo compared to moderate-hypo fractionated prostate IGRT with HDR brachytherapy boost. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02894-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
31
|
Martin A, De Bie B, O'Loughlin J. Anaesthesia for extraction of long-term cardiac device leads. BJA Educ 2022; 22:290-294. [PMID: 36097574 PMCID: PMC9463625 DOI: 10.1016/j.bjae.2022.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2022] [Indexed: 10/18/2022] Open
|
32
|
Good J, George B, Teoh S, Gaya A, Owens R, Aznar Garcia L, Robinson M, Martin A, Chu K, Mukherjee S, Maughan T. OC-0112 Feasibility and safety of daily adapted MR-guided SABR for pancreatic cancer in the UK. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02488-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Padden-Modi M, Cheng J, Kirby R, Twyman N, Aslam S, Bulusu V, Gilligan D, Martin A, Pipalia N, Shiarli A, Yang H, Thippu Jayaprakash K. PD-0670 Minimising radical radiotherapy commencement time for lung cancer to improve clinical outcomes. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02917-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Barré T, Mercié P, Lions C, Miailhes P, Zucman D, Aumaître H, Esterle L, Sogni P, Carrieri P, Salmon-Céron D, Marcellin F, Salmon D, Wittkop L, Sogni P, Esterle L, Trimoulet P, Izopet J, Serfaty L, Paradis V, Spire B, Carrieri P, Valantin MA, Pialoux G, Chas J, Poizot-Martin I, Barange K, Naqvi A, Rosenthal E, Bicart-See A, Bouchaud O, Gervais A, Lascoux-Combe C, Goujard C, Lacombe K, Duvivier C, Neau D, Morlat P, Bani-Sadr F, Meyer L, Boufassa F, Autran B, Roque AM, Solas C, Fontaine H, Costagliola D, Piroth L, Simon A, Zucman D, Boué F, Miailhes P, Billaud E, Aumaître H, Rey D, Peytavin G, Petrov-Sanchez V, Levier A, Usubillaga R, Terris B, Tremeaux P, Katlama C, Valantin MA, Stitou H, Cacoub P, Nafissa S, Benhamou Y, Charlotte F, Fourati S, Zaegel O, Laroche H, Tamalet C, Callard P, Bendjaballah F, Le Pendeven C, Marchou B, Alric L, Metivier S, Selves J, Larroquette F, Rio V, Haudebourg J, Saint-Paul MC, De Monte A, Giordanengo V, Partouche C, Martin A, Ziol M, Baazia Y, Iwaka-Bande V, Gerber A, Uzan M, Garipuy D, Ferro-Collados MJ, Nicot F, Yazdanpanah Y, Adle-Biassette H, Alexandre G, Molina JM, Bertheau P, Chaix ML, Delaugerre C, Maylin S, Bottero J, Krause J, Girard PM, Wendum D, Cervera P, Adam J, Viala C, Vittecocq D, Quertainmont Y, Teicher E, Pallier C, Lortholary O, Rouzaud C, Lourenco J, Touam F, Louisin C, Avettand-Fenoel V, Gardiennet E, Mélard A, Ochoa A, Blanchard E, Castet-Lafarie S, Cazanave C, Malvy D, Dupon M, Dutronc H, Dauchy F, Lacaze-Buzy L, Desclaux A, Bioulac-Sage P, Reigadas S, Lacoste D, Bonnet F, Bernard N, Hessamfar M, J, Paccalin F, Martell C, Pertusa MC, Vandenhende M, Mercié P, Pistone T, Receveur MC, Méchain M, Duffau P, Rivoisy C, Faure I, Caldato S, Bellecave P, Tumiotto C, Pellegrin JL, Viallard JF, Lazzaro E, Greib C, Majerholc C, Brollo M, Farfour E, Devoto JP, Kansau I, Chambrin V, Pignon C, Berroukeche L, Fior R, Martinez V, Abgrall S, Favier M, Deback C, Lévy Y, Dominguez S, Lelièvre JD, Lascaux AS, Melica G, Raffi F, Allavena C, Reliquet V, Boutoille D, Biron C, Lefebvre M, Hall N, Bouchez S, Rodallec A, Le Guen L, Hemon C, Peyramond D, Chidiac C, Ader F, Biron F, Boibieux A, Cotte L, Ferry T, Perpoint T, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Amiri M, Valour F, Augustin-Normand C, Scholtes C, Le-Thi TT, Van Huyen PCMD, Buisson M, Waldner-Combernoux A, Mahy S, Rousseau AS, Martins C, Galim S, Lambert D, Nguyen Y, Berger JL, Hentzien M, Brodard V, Partisani M, Batard ML, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Fischer P, Gantner P, Fafi-Kremer S, Roustant F, Platterier P, Kmiec I, Traore L, Lepuil S, Parlier S, Sicart-Payssan V, Bedel E, Anriamiandrisoa S, Pomes C, Mole M, Bolliot C, Catalan P, Mebarki M, Adda-Lievin A, Thilbaut P, Ousidhoum Y, Makhoukhi FZ, Braik O, Bayoud R, Gatey C, Pietri MP, Le Baut V, Rayana RB, Bornarel D, Chesnel C, Beniken D, Pauchard M, Akel S, Lions C, Ivanova A, Ritleg AS, Debreux C, Chalal L, Zelie J, Hue H, Soria A, Cavellec M, Breau S, Joulie A, Fisher P, Gohier S, Croisier-Bertin D, Ogoudjobi S, Brochier C, Thoirain-Galvan V, Le Cam M, Chalouni M, Conte V, Dequae-Merchadou L, Desvallees M, Gilbert C, Gillet S, Knight R, Lemboub T, Marcellin F, Michel L, Mora M, Protopopescu C, Roux P, Tezkratt S, Barré T, Rojas TR, Baudoin M, Di Beo MSV, Nishimwe M. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data). AIDS Res Ther 2022; 19:15. [PMID: 35292069 PMCID: PMC8922772 DOI: 10.1186/s12981-022-00440-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 03/06/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and HIV-HCV co-infected patients. HCV cure is likely to foster behavioral changes in psychoactive substance use, which is highly prevalent in people living with HIV (PLWH). Cannabis is one substance that is very commonly used by PLWH, sometimes for therapeutic purposes. We aimed to identify correlates of cannabis use reduction following HCV cure in HIV-HCV co-infected cannabis users and to characterize persons who reduced their use. METHODS We used data collected on HCV-cured cannabis users in a cross-sectional survey nested in the ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients, to perform logistic regression, with post-HCV cure cannabis reduction as the outcome, and socio-behavioral characteristics as potential correlates. We also characterized the study sample by comparing post-cure substance use behaviors between those who reduced their cannabis use and those who did not. RESULTS Among 140 HIV-infected cannabis users, 50 and 5 had reduced and increased their use, respectively, while 85 had not changed their use since HCV cure. Cannabis use reduction was significantly associated with tobacco use reduction, a decrease in fatigue level, paying more attention to one's dietary habits since HCV cure, and pre-HCV cure alcohol abstinence (p = 0.063 for alcohol use reduction). CONCLUSIONS Among PLWH using cannabis, post-HCV cure cannabis reduction was associated with tobacco use reduction, improved well-being, and adoption of healthy behaviors. The management of addictive behaviors should therefore be encouraged during HCV treatment.
Collapse
|
35
|
Killeen E, Horan S, Pollock A, Lee A, Martin A. 744 3 YEAR FOLLOW-UP OF SEDATIVE PRESCRIBING FOR RESPONSIVE BEHAVIOURS IN NURSING HOME RESIDENTS, AN IRISH STUDY. Age Ageing 2022. [DOI: 10.1093/ageing/afac034.744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Sedative medications are commonly prescribed for older adults; these include neuroleptics, benzodiazepines, opioids, ‘z’ drugs and trazadone. The prevalence of sedative drug prescriptions is increasing (1). Nursing home residents are three times more likely to be prescribed benzodiazepines (2). Regular medication review and education have been shown to reduce rates of sedative use in nursing homes (3). We previously demonstrated a significant reduction in prescription of these target medications at an Irish nursing home with specific focus, within scheduled medication reviews, on reduction or discontinuation of the target drugs in combination with education on management of Behavioural and Psychological symptoms (BPSD). This audit examines the prescribing patterns 3 years on from the initial audit.
Methods
Point prevalence study of sedative prescriptions and BPSD of all 95 nursing home residents on 6/5/21. Comparison with data from two previous audits in the same unit. All data was anonymised. Data analysed with SPSS statistical software.
Results
Sustained significant drop in quetiapine use from 30% of residents to 14% post-intervention in 2018 and three-year follow-up (p = 0.06). Borderline significant reduction in overall neuroleptics (from 39% to 25%, p = 0.06). Significant rise in ‘z’ drug prescription (from 8% to 17%, p = 0.03). BPSD reported in 33%, compared to 49% pre-intervention.
Conclusion
Regularly scheduled medication reviews can effectively rationalise sedative prescription rates in nursing home residents. Increasing ‘z’ drug prescription likely represents the appropriate replacement of neuroleptics. Reduced BPSD may be due to reporting bias of staff since regular education has been introduced or changing cohort of residents. References numbered above not included given limited word count.
Collapse
Affiliation(s)
| | - S Horan
- Health Service Executive, Ireland
| | | | - A Lee
- Health Service Executive, Ireland
| | - A Martin
- Health Service Executive, Ireland
| |
Collapse
|
36
|
Weishaupt LL, Vuong T, Thibodeau-Antonacci A, Garant A, Singh KS, Miller C, Martin A, Enger S. A121 QUANTIFYING INTER-OBSERVER VARIABILITY IN THE SEGMENTATION OF RECTAL TUMORS IN ENDOSCOPY IMAGES AND ITS EFFECTS ON DEEP LEARNING. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859391 DOI: 10.1093/jcag/gwab049.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background Tumor delineation in endoscopy images is a crucial part of clinical diagnoses and treatment planning for rectal cancer patients. However, it is challenging to detect and adequately determine the size of tumors in these images, especially for inexperienced clinicians. This motivates the need for a standardized, automated segmentation method. While deep learning has proven to be a powerful tool for medical image segmentation, it requires a large quantity of high-quality annotated training data. Since the annotation of endoscopy images is prone to high inter-observer variability, creating a robust unbiased deep learning model for this task is challenging. Aims To quantify the inter-observer variability in the manual segmentation of tumors in endoscopy images of rectal cancer patients and investigate an automated approach using deep learning. Methods Three gastrointestinal physicians and radiation oncologists (G1, G2, and G3) segmented 2833 endoscopy images into tumor and non-tumor regions. The whole image classifications and the pixelwise classifications into tumor and non-tumor were compared to quantify the inter-observer variability. Each manual annotator is from a different institution. Three different deep learning architectures (FCN32, U-Net, and SegNet) were trained on the binary contours created by G2. This naive approach investigates the effectiveness of neglecting any information about the uncertainty associated with the task of tumor delineation. Finally, segmentations from G2 and the deep learning models’ predictions were compared against ground truth labels from G1 and G3, and accuracy, sensitivity, specificity, precision, and F1 scores were computed for images where both segmentations contained tumors. Results The deep-learning segmentation took less than 1 second, while manual segmentation took approximately 10 seconds per image. There was significant inter-observer variability for the whole-image classifications made by the manual annotators (Figure 1A). The segmentation scores achieved by the deep learning models (SegNet F1:0.80±0.08) were comparable to the inter-observer variability for the pixel-wise image classification (Figure 1B). Conclusions The large inter-observer variability observed in this study indicates a need for an automated segmentation tool for tumors in endoscopy images of rectal cancer patients. While deep learning models trained on a single observer’s labels can segment tumors with an accuracy similar to the inter-observer variability, these models do not accurately reflect the intrinsic uncertainty associated with tumor delineation. In our ongoing studies, we investigate training a model with all observers’ contours to reflect the uncertainty associated with the tumor segmentations. Funding Agencies CIHRNSERC
Collapse
Affiliation(s)
- L L Weishaupt
- Medical Physics, McGill University, Montreal, QC, Canada
| | - T Vuong
- Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada
| | | | - A Garant
- The University of Texas Southwestern Medical Center Department of Neuroscience, Dallas, TX
| | - K S Singh
- Medical Physics, McGill University, Montreal, QC, Canada
| | - C Miller
- Medical Physics, McGill University, Montreal, QC, Canada
| | - A Martin
- CHU de Quebec-Universite Laval, Quebec, QC, Canada
| | - S Enger
- Medical Physics, McGill University, Montreal, QC, Canada
| |
Collapse
|
37
|
Wan R, Docherty C, Bhatti H, Shin H, Spector C, Thai B, Muller A, Martin A, Gile K, Liu A, Ong A, Chen H. TRACHEOSTOMY DISLODGEMENT: ARE OBESE PATIENTS AT INCREASED LONG -TERM RISK? Am J Surg 2022; 223:569-570. [DOI: 10.1016/j.amjsurg.2022.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
38
|
Gobin L, Vallée A, Zucman D, Carbonnel M, Laperrelle J, Brugière O, Martin A, Ayoubi JM, Farfour E. COVID-19 reinfection after pregnancy. Infect Dis Now 2022; 52:101-103. [PMID: 35065269 PMCID: PMC8769937 DOI: 10.1016/j.idnow.2022.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 12/24/2021] [Accepted: 01/10/2022] [Indexed: 11/17/2022]
Abstract
Background There have been reports of COVID-19 reinfections, but the immunological characterization of these cases is partial. We report a case of reinfection with SARS-CoV-2, where the first infection occurred in the course of late pregnancy. Case presentation On May 27, 2020, a 37-year-old woman gave birth at full term, 3 hours after full dilatation. She developed fever (38.3 °C) after delivery. Mild biological anomalies compatible with COVID-19 were observed: lymphopenia, thrombocytopenia, elevated D-Dimers, CRP, and LDH. At 6-month follow-up, she reported having contracted COVID-19 with high fever, rhinorrhea, hand frostbites, cough, headache, dysgeusia and anosmia. Conclusions We report a case of COVID-19 reinfection with a first mild infection during late pregnancy and a more aggressive second infection 5 months later.
Collapse
Affiliation(s)
- L Gobin
- Department of Clinical Research and Innovation, Foch Hospital, Suresnes, France.
| | - A Vallée
- Department of Clinical Research and Innovation, Foch Hospital, Suresnes, France.
| | - D Zucman
- Internal Medicine, Foch Hospital, Suresnes, France.
| | - M Carbonnel
- Department of Obstetrics Gynecology and Reproductive Medicine, Foch Hospital, Suresnes, France.
| | - J Laperrelle
- Department of Obstetrics Gynecology and Reproductive Medicine, Foch Hospital, Suresnes, France.
| | - O Brugière
- Lung Transplant Center and Center of Expertise for Cystic Fibrosis, Foch Hospital, Suresnes, France.
| | - A Martin
- Department of Clinical Research and Innovation, Foch Hospital, Suresnes, France.
| | - J-M Ayoubi
- Department of Obstetrics Gynecology and Reproductive Medicine, Foch Hospital, Suresnes, France.
| | - E Farfour
- Internal Medicine, Foch Hospital, Suresnes, France.
| |
Collapse
|
39
|
Prykhodko Y, Martin A, Oulyadi H, Kobzar YL, Marais S, Fatyeyeva K. Imidazolium-based protic ionic liquids with perfluorinated anions: Influence of chemical structure on thermal properties. J Mol Liq 2022. [DOI: 10.1016/j.molliq.2021.117782] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Whearty L, Lever N, Martin A. Outcomes of Transvenous Lead Extraction in New Zealand. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
41
|
De Seta F, Johnson Z, Stabile G, Martin A, Larsen B. Rational development and evaluation of novel formulations for urinary health. Eur J Obstet Gynecol Reprod Biol 2021; 269:90-97. [PMID: 34979364 DOI: 10.1016/j.ejogrb.2021.12.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Accepted: 12/23/2021] [Indexed: 11/04/2022]
Abstract
OBJECTIVE Urinary tract infections (UTI) among women form a substantial part of medical practice and both patients and medical professionals have an interest in non-antibiotic treatments and preventative measures. This research provides preliminary data on a multi-functional composition, DAPAD, which explored several biologic activities of relevance to UTI. STUDY DESIGN This formulation included D-mannose, citric acid, three prebiotic compounds, and extracts of dandelion and astragalus. Studies performed employed 4 bacterial strains that have relevance to UTI including E. coli, Proteus mirabilis, Streptococcus agalactiae and Enterococcus faecalis. RESULTS Key findings from in vitro studies included: DAPAD at full- and half-strength inhibited growth of all UTI bacteria. Evidence for D-mannose agglutination of E. coli was demonstrated. D-mannose also showed unexpected effects on bacterial membrane integrity with vital staining and modest growth restriction. We did not demonstrate growth inhibition by dandelion or astragalus extracts but the latter showed diminished cytokine elaboration by bladder epithelial cells. CONCLUSION DAPAD is a multifunctional composition that may warrant further development as a UTI treatment or preventive if supported by clinical evaluation.
Collapse
Affiliation(s)
- Francesco De Seta
- Department of Medical Sciences, University of Trieste, Institute for Maternal and Child Health- IRCCS, Burlo Garofolo, Trieste, Italy
| | - Zoe Johnson
- OB/GYN PGY1, Metro Health Hospital, Wyoming, MI, USA
| | - Guglielmo Stabile
- Institute for Maternal and Child Health-IRCCS, Burlo Garofolo, Trieste, Italy.
| | | | - Bryan Larsen
- Marian University College of Osteopathic Medicine (Retired), Indianapolis, IN, USA
| |
Collapse
|
42
|
Eqbal A, Martin A, Doecke JD, Patrick D. Low dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines. Intern Med J 2021; 53:559-567. [PMID: 34874611 DOI: 10.1111/imj.15639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Revised: 11/18/2021] [Accepted: 11/25/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND AND AIMS Thioguanine is an alternative thiopurine for IBD patients. We evaluated the short-term efficacy and safety of low dose therapeutic drug monitored (TDM) thioguanine. METHODS A retrospective evaluation of IBD patients intolerant to conventional thiopurines started on thioguanine from 2017-2019 with dosing guided by TDM was conducted. Clinical response was defined for Ulcerative colitis (UC) as a reduction of partial MAYO score ≥ 3 with reduction in rectal bleeding score of at least 1 and a final rectal bleeding sub score of 0-1 at week 12 of therapy. Crohn's disease (CD) response was defined as a reduction of Harvey-Bradshaw index ≥ 3 (HBI) at week 12 of therapy. Remission was defined in UC as partial MAYO score of < 2 and in CD as HBI score of < 5. RESULTS 46 patients were included in the study. The median thioguanine dose was 20 mg/day (SD 7.3, range: 10-40 mg/day) with a median 6-TGN level of 564 pmol/8×108 (IQR 517) for CD and 672 pmol/8×108 (IQR 349) for UC. The overall clinical response rate was 62% (13/21), intention to treat (ITT). Maintenance of remission was 76% (19/25, ITT). 37% (17/46) of patients experienced an adverse effect. No early cases of NRH were seen. CONCLUSION Thioguanine was tolerated well in 63% of patients. Clinical response was seen in 62 % of and maintenance of remission was high at 76 %. No cases of early NRH were seen. Longer-term follow-up is required to ensure safety and to assess durability of response. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- A Eqbal
- Department of Gastroenterology and Hepatology, Sunshine Coast University Public Hospital, Sunshine Coast, Queensland, Australia
| | - A Martin
- Department of Gastroenterology and Hepatology, Sunshine Coast University Public Hospital, Sunshine Coast, Queensland, Australia
| | - J D Doecke
- Department of Gastroenterology and Hepatology, Sunshine Coast University Public Hospital, Sunshine Coast, Queensland, Australia.,CSIRO Health and Biosecurity/Australian E-Health Research Centre, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
| | - D Patrick
- Department of Gastroenterology and Hepatology, Sunshine Coast University Public Hospital, Sunshine Coast, Queensland, Australia
| |
Collapse
|
43
|
Killeen E, Horan S, Pollock A, Lee A, Martin A. 98 SCHEDULED MEDICATION REVIEWS AND EDUCATION ON SEDATIVE PRESCRIBING FOR RESPONSIVE BEHAVIOURS IN NURSING HOME RESIDENTS, A 3 YEAR FOLLOW-UP STUDY. Age Ageing 2021. [DOI: 10.1093/ageing/afab219.98] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Abstract
Background
Sedative medications including neuroleptics, benzodiazepines, opioids, ‘z’ drugs and trazadone are commonly prescribed for older adults. Nursing home residents are three times more likely to be prescribed benzodiazepines. Sedative medications are associated with significant risks including falls and delirium in older adults. Neuroleptics also increase risk of cerebrovascular disease and functional decline. Regular medication review and education have been shown to reduce rates of sedative use in nursing homes. Scheduled medication reviews were introduced in an Irish nursing home with a specific focus on reduction or discontinuation of these target medications in combination with education of management of Behavioural and Psychological symptoms (BPSD). We demonstrated previously a significant reduction in prescribing following these interventions. This audit examines the prescribing patterns 3 years on from the initial audit.
Methods
Point prevalence study of sedative prescriptions and BPSD on 6/5/21 of all 95 nursing home residents. Data compared with two preceding audits in 2018 in the same unit. All data anonymised. Data analysed with SPSS statistical software.
Results
Significant reduction in quetiapine use sustained from 30% of residents pre-intervention to 14% post-intervention in 2018 and 2021 (p = 0.06).
Neuroleptic prescription reduced from 39% to 25% (p = 0.06).
‘Z’ drug prescribing increased from 8% to 17% (p = 0.03).
33% of residents had BPSD reported compared to 49% pre-intervention.
Conclusion
3 year follow-up showed regularly scheduled medication reviews and education in a nursing home can effectively rationalise sedative prescription rates. Sustained reduction in neuroleptics and increased ‘z’ drug prescriptions may represent appropriate replacement. Reduced BPSD may be due to changing nursing home resident cohort or reporting bias of staff since the introduction of regular education.
Collapse
Affiliation(s)
| | - S Horan
- Beaumont Hospital , Dublin, Ireland
| | | | - A Lee
- Beaumont Hospital , Dublin, Ireland
| | - A Martin
- Beaumont Hospital , Dublin, Ireland
| |
Collapse
|
44
|
Ostler P, Hoskin P, Martin A. Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy? Clin Oncol (R Coll Radiol) 2021; 33:747-748. [PMID: 34642067 DOI: 10.1016/j.clon.2021.09.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 09/02/2021] [Accepted: 09/20/2021] [Indexed: 10/20/2022]
Affiliation(s)
- P Ostler
- Mount Vernon Cancer Centre, Northwood, UK.
| | - P Hoskin
- Mount Vernon Cancer Centre, Northwood, UK; University of Manchester, Manchester, UK
| | - A Martin
- Addenbrooke's Hospital, Cambridge, UK
| |
Collapse
|
45
|
Martin A, Breskovic T, Ouss A, Dekker L, Yap SC, Bhagwandien R, Cielen N, Albrecht EM, Richards E, Tran B, Lever N, Anic A. Novel cryoballoon to isolate pulmonary veins in patients with paroxysmal atrial fibrillation: one-year outcomes in a multicenter study. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Recently, a novel cryoballoon (CB; POLARx) has been developed with increased steerability which maintains size and pressure throughout the ablation. Initial clinical data has demonstrated acute procedural safety and efficacy in de novo pulmonary vein isolation (PVI) procedures in patients with paroxysmal atrial fibrillation (AF). However, there are limited studies demonstrating the long-term efficacy of the CB.
Purpose
To evaluate the long-term safety and efficacy of the novel CB in treating paroxysmal AF.
Methods
This was a non-randomized, prospective, multi-center study. Fifty-eight consecutive patients with paroxysmal AF were enrolled at 4 centers for de novo PVI procedures. Cryoablation was delivered for 180s if time to isolation was ≤60s. Otherwise a 240s cryoablation was performed. PVI was confirmed with entrance and exit block testing. Patients were followed for 1 year with 24-hour Holter monitoring at 3, 6, and 12 months. After a 3-month blanking period, recurrence was defined as having any documented, symptomatic episode(s) of AF or atrial tachycardia.
Results
Acute isolation with the CB was achieved in 230 of 231 pulmonary veins (99.6%) with 5.2±1.5 cryoapplications per patient (1.3±0.6 cryoapplications per vein). There were 4 patients (6.9%) with phrenic nerve injury (3 resolved during the index procedure; 1 resolved at 6 months follow-up). One serious adverse device event was reported: femoral arterial embolism event occurring 2 weeks post index procedure (1.7%). Of the 56 patients that had complete 12-month follow-up, 43 (76.8%) were free from recurrent atrial arrhythmias.
Conclusion
Initial multicenter clinical experience with the novel CB has demonstrated long-term safety and efficacy of PVI in patients with paroxysmal AF. Further studies are underway to confirm these findings.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Boston Scientific
Collapse
Affiliation(s)
- A Martin
- Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand
| | - T Breskovic
- University Hospital Center Split, Split, Croatia
| | - A Ouss
- Catharina Hospital, Eindhoven, Netherlands (The)
| | - L Dekker
- Catharina Hospital, Eindhoven, Netherlands (The)
| | - S C Yap
- Erasmus University Medical Centre, Rotterdam, Netherlands (The)
| | - R Bhagwandien
- Erasmus University Medical Centre, Rotterdam, Netherlands (The)
| | - N Cielen
- Boston Scientific, Brussels, Belgium
| | - E M Albrecht
- Boston Scientific, St. Paul, United States of America
| | - E Richards
- Boston Scientific, St. Paul, United States of America
| | - B Tran
- Boston Scientific, St. Paul, United States of America
| | - N Lever
- Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand
| | - A Anic
- University Hospital Center Split, Split, Croatia
| |
Collapse
|
46
|
Martin A, Zhou P, Singh BB, Kotsakis GA. Transcriptome-wide Gene Expression Analysis in Peri-implantitis Reveals Candidate Cellular Pathways. JDR Clin Trans Res 2021; 7:415-424. [PMID: 34583558 DOI: 10.1177/23800844211045297] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVE Peri-implantitis is a condition resulting in destructive inflammation in the peri-implant soft tissue barrier. Clinically, it demonstrates vast clinical differences to periodontitis that suggest distinct inflammatory mechanisms. Implant-derived titanium particles (i-TiPs) frequently found around diseased implants appear to alter the microenvironment and confer resistance to antibiotic treatments. Studies in orthopedic implants have demonstrated potent inflammatory responses to i-TiPs involving a variety of cell types in aseptic conditions. Nonetheless, the genetic programs of cells surveilling and supporting the peri-implant soft tissue barrier in response to the combined challenges of biomaterial degradation products and oral bacteria are poorly defined. Thus, we studied gene expression specific to oral peri-implant inflammatory disease. METHODS Peri-implant tissues were collected from healthy or diseased implants (N = 10) according to the 2018 classification criteria. Following RNA extraction and purification, a gene-level view of the transcriptome was obtained via a next-generation transcriptome-wide microarray profiling workflow (Clariom S; Applied Biosystems) that covers >20,000 well-annotated genes. A discovery analysis assessed global differential expression of genes and identified pathways in peri-implant health versus disease. RESULTS Genes involved in the endosomal-lysosomal pathway, such as actin polymerization, were strongly upregulated in diseased tissues (P < .05), proposing increased intracellular activities in response to bacteria and i-TiPs. Cellular respiration pathways involved in oxidative stress were highly transcribed in all peri-implant samples, suggesting that implant-specific factors may trigger a constant state of oxidative stress. CONCLUSION Within the limitations of this discovery study, expressive upregulation of genes in the endosomal-lysosomal and oxidative stress pathway suggests that inflammation related to receptor-driven responses to extracellular signals, such as i-TiPs and pathogens, may have a crucial role in peri-implantitis. Results warrant external replication in validation cohorts. KNOWLEDGE TRANSFER STATEMENT Our findings regarding physiologic processes affected by peri-implantitis could advance knowledge of the mechanisms and consequences of the disease. Understanding the cellular programs that partake in peri-implant inflammation has the potential to translate to novel treatment strategies for patients with peri-implantitis.
Collapse
Affiliation(s)
- A Martin
- Translational Periodontal Research Lab, Department of Periodontics, School of Dentistry, UT Health San Antonio, San Antonio, TX, USA
| | - P Zhou
- Translational Periodontal Research Lab, Department of Periodontics, School of Dentistry, UT Health San Antonio, San Antonio, TX, USA
| | - B B Singh
- Singh Lab, Department of Periodontics, School of Dentistry, UT Health San Antonio, San Antonio, TX, USA
| | - G A Kotsakis
- Translational Periodontal Research Lab, Department of Periodontics, School of Dentistry, UT Health San Antonio, San Antonio, TX, USA
| |
Collapse
|
47
|
Brown J, Royle KL, Ralph C, Meads D, Martin A, Howard H, Linsley C, Swain J, Powles T, Jones R, Eisen T, Maraveyas A, Griffiths R, Din O, Goh V, Wah T, Selby P, Hewison J, Brown J, Collinson F. LBA28 STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
48
|
Martin A, Montavon G, Landesman C. A combined DGT - DET approach for an in situ investigation of uranium resupply from large soil profiles in a wetland impacted by former mining activities. Chemosphere 2021; 279:130526. [PMID: 33862359 DOI: 10.1016/j.chemosphere.2021.130526] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Revised: 04/01/2021] [Accepted: 04/05/2021] [Indexed: 06/12/2023]
Abstract
An in situ methodology combining DET and DGT probes was applied in a wetland soil, downstream of a former uranium mine (Rophin), to evaluate metal resupply by calculating the R ratio (R = [U]DGT/[U]pore water) from a high resolution and large (75 cm) soil profile. Our study confirms its applicability in soil layers with varying properties; only soil layers with low water content or coarse texture appear to be limiting factors. For soil profiles, DET provides new insights of the distribution of Uranium as soluble species (free ions, small inorganic complexes, …) along the pore water profile, whereas DGT highlights the presence of other "DGT labile" species. The pairing of DET and DGT, plus the calculation of the R, highlights two U behaviors in combining results from red-ox sensitive elements (Mn, Fe). First, in the organic topsoil layer, an increase in [U]DET and [U]DGT at 3-4 cm reflects the desorption of U probably trapped onto Fe- and Mn-oxohydroxides in a DGT-labile form. However, the resupply from soil to pore water is close to a diffusion only case (R < 0.2) meaning that a portion of U is certainly tightly bound by OM in soil as non-labile species. Second, a peak in [U]DGT perfectly corresponding to the former mine deposit layer signifies the presence of U under DGT-labile species. Moreover, a maximum R value of 0.87 demonstrates the near complete resupply of U from a labile fraction in this layer, as opposed to other elements like Pb.
Collapse
Affiliation(s)
- A Martin
- SUBATECH, UMR 6457 (IMT-Atlantique, Université de Nantes, CNRS-IN2P3), 4 Rue Alfred Kastler, 44307, Nantes, France
| | - G Montavon
- SUBATECH, UMR 6457 (IMT-Atlantique, Université de Nantes, CNRS-IN2P3), 4 Rue Alfred Kastler, 44307, Nantes, France; LTSER "Zone Atelier Territoires Uranifères", 63000, Clermont-Ferrand, France
| | - C Landesman
- SUBATECH, UMR 6457 (IMT-Atlantique, Université de Nantes, CNRS-IN2P3), 4 Rue Alfred Kastler, 44307, Nantes, France.
| |
Collapse
|
49
|
Alexeev GD, Alexeev MG, Amoroso A, Andrieux V, Anosov V, Antoshkin A, Augsten K, Augustyniak W, Azevedo CDR, Badełek B, Balestra F, Ball M, Barth J, Beck R, Bedfer Y, Berenguer Antequera J, Bernhard J, Bodlak M, Bradamante F, Bressan A, Burtsev VE, Chang WC, Chatterjee C, Chiosso M, Chumakov AG, Chung SU, Cicuttin A, Correia PMM, Crespo ML, D'Ago D, Dalla Torre S, Dasgupta SS, Dasgupta S, Denisenko I, Denisov OY, Donskov SV, Doshita N, Dreisbach C, Dünnweber W, Dusaev RR, Efremov A, Eversheim PD, Faccioli P, Faessler M, Finger M, Finger M, Fischer H, Franco C, Friedrich JM, Frolov V, Gautheron F, Gavrichtchouk OP, Gerassimov S, Giarra J, Gnesi I, Gorzellik M, Grasso A, Gridin A, Grosse Perdekamp M, Grube B, Guskov A, von Harrach D, Heitz R, Herrmann F, Horikawa N, d'Hose N, Hsieh CY, Huber S, Ishimoto S, Ivanov A, Iwata T, Jandek M, Jary V, Joosten R, Jörg P, Kabuß E, Kaspar F, Kerbizi A, Ketzer B, Khaustov GV, Khokhlov YA, Kisselev Y, Klein F, Koivuniemi JH, Kolosov VN, Kondo Horikawa K, Konorov I, Konstantinov VF, Kotzinian AM, Kouznetsov OM, Koval A, Kral Z, Krinner F, Kulinich Y, Kunne F, Kurek K, Kurjata RP, Kveton A, Lavickova K, Levorato S, Lian YS, Lichtenstadt J, Lin PJ, Longo R, Lyubovitskij VE, Maggiora A, Magnon A, Makins N, Makke N, Mallot GK, Maltsev A, Mamon SA, Marianski B, Martin A, Marzec J, Matoušek J, Matsuda T, Mattson G, Meshcheryakov GV, Meyer M, Meyer W, Mikhailov YV, Mikhasenko M, Mitrofanov E, Mitrofanov N, Miyachi Y, Moretti A, Nagaytsev A, Naim C, Neyret D, Nový J, Nowak WD, Nukazuka G, Nunes AS, Olshevsky AG, Ostrick M, Panzieri D, Parsamyan B, Paul S, Pekeler H, Peng JC, Pešek M, Peshekhonov DV, Pešková M, Pierre N, Platchkov S, Pochodzalla J, Polyakov VA, Pretz J, Quaresma M, Quintans C, Reicherz G, Riedl C, Rudnicki T, Ryabchikov DI, Rybnikov A, Rychter A, Samoylenko VD, Sandacz A, Sarkar S, Savin IA, Sbrizzai G, Schmieden H, Selyunin A, Sinha L, Slunecka M, Smolik J, Srnka A, Steffen D, Stolarski M, Subrt O, Sulc M, Suzuki H, Sznajder P, Tessaro S, Tessarotto F, Thiel A, Tomsa J, Tosello F, Townsend A, Tskhay V, Uhl S, Vasilishin BI, Vauth A, Veit BM, Veloso J, Ventura B, Vidon A, Virius M, Wagner M, Wallner S, Zaremba K, Zavada P, Zavertyaev M, Zemko M, Zemlyanichkina E, Zhao Y, Ziembicki M. Triangle Singularity as the Origin of the a_{1}(1420). Phys Rev Lett 2021; 127:082501. [PMID: 34477443 DOI: 10.1103/physrevlett.127.082501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 05/04/2021] [Accepted: 05/26/2021] [Indexed: 06/13/2023]
Abstract
The COMPASS Collaboration experiment recently discovered a new isovector resonancelike signal with axial-vector quantum numbers, the a_{1}(1420), decaying to f_{0}(980)π. With a mass too close to and a width smaller than the axial-vector ground state a_{1}(1260), it was immediately interpreted as a new light exotic meson, similar to the X, Y, Z states in the hidden-charm sector. We show that a resonancelike signal fully matching the experimental data is produced by the decay of the a_{1}(1260) resonance into K^{*}(→Kπ)K[over ¯] and subsequent rescattering through a triangle singularity into the coupled f_{0}(980)π channel. The amplitude for this process is calculated using a new approach based on dispersion relations. The triangle-singularity model is fitted to the partial-wave data of the COMPASS experiment. Despite having fewer parameters, this fit shows a slightly better quality than the one using a resonance hypothesis and thus eliminates the need for an additional resonance in order to describe the data. We thereby demonstrate for the first time in the light-meson sector that a resonancelike structure in the experimental data can be described by rescattering through a triangle singularity, providing evidence for a genuine three-body effect.
Collapse
Affiliation(s)
- G D Alexeev
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M G Alexeev
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - A Amoroso
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - V Andrieux
- CERN, 1211 Geneva 23, Switzerland
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - V Anosov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - A Antoshkin
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - K Augsten
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - W Augustyniak
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - C D R Azevedo
- Department of Physics, University of Aveiro, I3N, 3810-193 Aveiro, Portugal
| | - B Badełek
- Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland
| | - F Balestra
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - M Ball
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - J Barth
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - Y Bedfer
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - J Berenguer Antequera
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - J Bernhard
- CERN, 1211 Geneva 23, Switzerland
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - M Bodlak
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | | | - A Bressan
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - V E Burtsev
- Tomsk Polytechnic University, 634050 Tomsk, Russia
| | - W-C Chang
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
| | - C Chatterjee
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - M Chiosso
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - A G Chumakov
- Tomsk Polytechnic University, 634050 Tomsk, Russia
| | - S-U Chung
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - A Cicuttin
- Trieste Section of INFN, 34127 Trieste, Italy
| | - P M M Correia
- Department of Physics, University of Aveiro, I3N, 3810-193 Aveiro, Portugal
| | - M L Crespo
- Trieste Section of INFN, 34127 Trieste, Italy
| | - D D'Ago
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | | | - S S Dasgupta
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
| | - S Dasgupta
- Trieste Section of INFN, 34127 Trieste, Italy
| | - I Denisenko
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | | | - S V Donskov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - N Doshita
- Yamagata University, Yamagata 992-8510, Japan
| | - Ch Dreisbach
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - W Dünnweber
- Department of Physics, University of Aveiro, I3N, 3810-193 Aveiro, Portugal
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- Institute of Scientific Instruments of the CAS, 61264 Brno, Czech Republic
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
- CERN, 1211 Geneva 23, Switzerland
- Technical University in Liberec, 46117 Liberec, Czech Republic
- LIP, 1649-003 Lisbon, Portugal
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
- University of Miyazaki, Miyazaki 889-2192, Japan
- Lebedev Physical Institute, 119991 Moscow, Russia
- Physik Department, Technische Universität München, 85748 Garching, Germany
- Nagoya University, 464 Nagoya, Japan
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
- Czech Technical University in Prague, 16636 Prague, Czech Republic
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
- School of Physics and Astronomy, Tel Aviv University, 69978 Tel Aviv, Israel
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
- Tomsk Polytechnic University, 634050 Tomsk, Russia
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
- Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
- Yamagata University, Yamagata 992-8510, Japan
| | - R R Dusaev
- Tomsk Polytechnic University, 634050 Tomsk, Russia
| | - A Efremov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - P D Eversheim
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | | | - M Faessler
- Department of Physics, University of Aveiro, I3N, 3810-193 Aveiro, Portugal
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- Institute of Scientific Instruments of the CAS, 61264 Brno, Czech Republic
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
- CERN, 1211 Geneva 23, Switzerland
- Technical University in Liberec, 46117 Liberec, Czech Republic
- LIP, 1649-003 Lisbon, Portugal
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
- University of Miyazaki, Miyazaki 889-2192, Japan
- Lebedev Physical Institute, 119991 Moscow, Russia
- Physik Department, Technische Universität München, 85748 Garching, Germany
- Nagoya University, 464 Nagoya, Japan
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
- Czech Technical University in Prague, 16636 Prague, Czech Republic
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
- School of Physics and Astronomy, Tel Aviv University, 69978 Tel Aviv, Israel
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
- Tomsk Polytechnic University, 634050 Tomsk, Russia
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
- Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
- Yamagata University, Yamagata 992-8510, Japan
| | - M Finger
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - M Finger
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - H Fischer
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | | | - J M Friedrich
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - V Frolov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
- CERN, 1211 Geneva 23, Switzerland
| | - F Gautheron
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - O P Gavrichtchouk
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - S Gerassimov
- Lebedev Physical Institute, 119991 Moscow, Russia
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - J Giarra
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - I Gnesi
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - M Gorzellik
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A Grasso
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - A Gridin
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M Grosse Perdekamp
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - B Grube
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - A Guskov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - D von Harrach
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - R Heitz
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - F Herrmann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | | | - N d'Hose
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - C-Y Hsieh
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
| | - S Huber
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - S Ishimoto
- Yamagata University, Yamagata 992-8510, Japan
| | - A Ivanov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - T Iwata
- Yamagata University, Yamagata 992-8510, Japan
| | - M Jandek
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - V Jary
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - R Joosten
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - P Jörg
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - E Kabuß
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - F Kaspar
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - A Kerbizi
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - B Ketzer
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - G V Khaustov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - Yu A Khokhlov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - Yu Kisselev
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - F Klein
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - J H Koivuniemi
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - V N Kolosov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | | | - I Konorov
- Lebedev Physical Institute, 119991 Moscow, Russia
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - V F Konstantinov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | | | - O M Kouznetsov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - A Koval
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - Z Kral
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - F Krinner
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - Y Kulinich
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - F Kunne
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - K Kurek
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - R P Kurjata
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
| | - A Kveton
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - K Lavickova
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - S Levorato
- CERN, 1211 Geneva 23, Switzerland
- Trieste Section of INFN, 34127 Trieste, Italy
| | - Y-S Lian
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
| | - J Lichtenstadt
- School of Physics and Astronomy, Tel Aviv University, 69978 Tel Aviv, Israel
| | - P-J Lin
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - R Longo
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | | | - A Maggiora
- Torino Section of INFN, 10125 Torino, Italy
| | - A Magnon
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
| | - N Makins
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - N Makke
- Trieste Section of INFN, 34127 Trieste, Italy
| | - G K Mallot
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
- CERN, 1211 Geneva 23, Switzerland
| | - A Maltsev
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - S A Mamon
- Tomsk Polytechnic University, 634050 Tomsk, Russia
| | - B Marianski
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - A Martin
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - J Marzec
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
| | - J Matoušek
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - T Matsuda
- University of Miyazaki, Miyazaki 889-2192, Japan
| | - G Mattson
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - G V Meshcheryakov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M Meyer
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - W Meyer
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
| | - Yu V Mikhailov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - M Mikhasenko
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
- CERN, 1211 Geneva 23, Switzerland
| | - E Mitrofanov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - N Mitrofanov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - Y Miyachi
- Yamagata University, Yamagata 992-8510, Japan
| | - A Moretti
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - A Nagaytsev
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - C Naim
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - D Neyret
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - J Nový
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - W-D Nowak
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - G Nukazuka
- Yamagata University, Yamagata 992-8510, Japan
| | | | - A G Olshevsky
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M Ostrick
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - D Panzieri
- Torino Section of INFN, 10125 Torino, Italy
| | - B Parsamyan
- Department of Physics, University of Torino, 10125 Torino, Italy
- Torino Section of INFN, 10125 Torino, Italy
| | - S Paul
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - H Pekeler
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - J-C Peng
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - M Pešek
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - D V Peshekhonov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M Pešková
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - N Pierre
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - S Platchkov
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - J Pochodzalla
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - V A Polyakov
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - J Pretz
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - M Quaresma
- LIP, 1649-003 Lisbon, Portugal
- Academia Sinica, Institute of Physics, Taipei 11529, Taiwan
| | | | - G Reicherz
- Institut für Experimentalphysik, Universität Bochum, 44780 Bochum, Germany
| | - C Riedl
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - T Rudnicki
- Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland
| | - D I Ryabchikov
- Physik Department, Technische Universität München, 85748 Garching, Germany
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - A Rybnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - A Rychter
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
| | - V D Samoylenko
- State Scientific Center Institute for High Energy Physics of National Research Center "Kurchatov Institute," 142281 Protvino, Russia
| | - A Sandacz
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - S Sarkar
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
| | - I A Savin
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - G Sbrizzai
- Department of Physics, University of Trieste, 34127 Trieste, Italy
- Trieste Section of INFN, 34127 Trieste, Italy
| | - H Schmieden
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - A Selyunin
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - L Sinha
- Matrivani Institute of Experimental Research & Education, Calcutta-700 030, India
| | - M Slunecka
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - J Smolik
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - A Srnka
- Institute of Scientific Instruments of the CAS, 61264 Brno, Czech Republic
| | - D Steffen
- CERN, 1211 Geneva 23, Switzerland
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | | | - O Subrt
- CERN, 1211 Geneva 23, Switzerland
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - M Sulc
- Technical University in Liberec, 46117 Liberec, Czech Republic
| | - H Suzuki
- Yamagata University, Yamagata 992-8510, Japan
| | - P Sznajder
- National Centre for Nuclear Research, 02-093 Warsaw, Poland
| | - S Tessaro
- Trieste Section of INFN, 34127 Trieste, Italy
| | - F Tessarotto
- CERN, 1211 Geneva 23, Switzerland
- Trieste Section of INFN, 34127 Trieste, Italy
| | - A Thiel
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - J Tomsa
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - F Tosello
- Torino Section of INFN, 10125 Torino, Italy
| | - A Townsend
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801-3080, USA
| | - V Tskhay
- Lebedev Physical Institute, 119991 Moscow, Russia
| | - S Uhl
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | | | - A Vauth
- Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- CERN, 1211 Geneva 23, Switzerland
| | - B M Veit
- CERN, 1211 Geneva 23, Switzerland
- Institut für Kernphysik, Universität Mainz, 55099 Mainz, Germany
| | - J Veloso
- Department of Physics, University of Aveiro, I3N, 3810-193 Aveiro, Portugal
| | - B Ventura
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - A Vidon
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - M Virius
- Czech Technical University in Prague, 16636 Prague, Czech Republic
| | - M Wagner
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, 53115 Bonn, Germany
| | - S Wallner
- Physik Department, Technische Universität München, 85748 Garching, Germany
| | - K Zaremba
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
| | - P Zavada
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - M Zavertyaev
- Lebedev Physical Institute, 119991 Moscow, Russia
| | - M Zemko
- CERN, 1211 Geneva 23, Switzerland
- Faculty of Mathematics and Physics, Charles University, 18000 Prague, Czech Republic
| | - E Zemlyanichkina
- Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
| | - Y Zhao
- Trieste Section of INFN, 34127 Trieste, Italy
| | - M Ziembicki
- Institute of Radioelectronics, Warsaw University of Technology, 00-665 Warsaw, Poland
| |
Collapse
|
50
|
Martin A, Carez S, Metzler-Guillemain C, Martial A. P–505 The right age to tell? The insufficiency of the age criteria for characterizing the experience of French donor conceived families in disclosing to their offspring. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Is age a key criteria for characterizing the experience of families in telling donor offspring about the facts of their conception?
Summary answer
The study shows that, although donor offspring’s age at the time of disclosure has an impact, it is insufficient to describe these families’ experiences
What is known already
Secrecy was the norm for decades in donor conception, but “openness” has now become the new core value for institutions, professionals and interest groups. Accordingly, in recent years information-sharing practices have shifted in donor conceived families, but a proportion of parents, especially heterosexual couples, still appear to not inform their children about their being donor conceived. Disclosure recommendations seem difficult to apply in practice. A recurring question is: when should children be told? Age is presented as a key criteria: the younger the children are when their conception story is shared, the less of a problem it would create.
Study design, size, duration
The qualitative social science study includes two sets of semi-directive interviews conducted with 20 French sperm donor conceived adults (April-Dec. 2019) and 22 French parents by sperm, egg or double donation (Feb.-Oct. 2020). Calls for interviews aimed at donor conceived adults and parents by donation were shared on the Internet, in the media (press, radio, television) and through interest groups (PMAnonyme, BAMP!, MAIA) in France. The contact initiative was left to potential participants.
Participants/materials, setting, methods
Donor conceived participants include 17 women and 3 men conceived 1960–2000 through anonymous sperm donation in heteroparental families.
The parent participants include 20 families (20 mothers, 2 fathers) who used donor conception—mainly anonymous (19)—in France, Spain and the Czech Republic starting in the 1980s. 17 conceived as heteroparental couples, 2 as solo-mothers-by-choice and 1 as a same-sex couple. 17 have already informed their offspring of the facts of their conception.
Main results and the role of chance
The participants’ experiences of disclosure appear to be bound to their historical and social context, especially regarding the prevailing norms on secrecy. Older parents mention having been advised by clinic professionals to keep the facts of their conception from their child(ren). Some also feared the stigma related to infertility. In contrast, some younger donor conceived participants recall the use of a children’s book while being told of their conception as toddlers. Beyond age, the larger context thus affects information-sharing practices.
Furthermore, experiences of disclosure are impacted by the family context and history. Some are embedded within larger events such as divorces or the death of a family member. The story of the donation may be linked to narratives of diseases (such as cancer) or traumatic events (such as the loss of a fetus in utero) that may prevail over donor conception or make it untellable.
Age proves to be an insufficient criteria to qualify these experiences, all the more so since “disclosure” sometimes unfolds in several steps. Some parents have first talked about their fertility issues without mentioning the use of a donor. Behind the prevailing norm of “openness”, difficulties in actually disclosing are confirmed.
Limitations, reasons for caution
Being qualitative, the study only includes a small number of participants without claiming exhaustivity nor representativity. It imperfectly reports on the view of those who do not disclose, as all participants question the principle of secrecy, many being members of interest groups defending openness.
Wider implications of the findings: Our results complement existing studies that emphasize the weight of age in donor conceived families’ experience regarding disclosure. Age alone cannot describe information-sharing practices that are embedded within their historical and social context as well as the family context and history. Results thus inform familial difficulties related to disclosure.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- A Martin
- Ecole des Hautes Etudes en Sciences Sociales- Centre Norbert Elias, Social Anthropology, Marseille, France
| | - S Carez
- AP-HM La Conception- Biologie de la Reproduction-CECOS, Psychology, Marseille, France
| | - C Metzler-Guillemain
- AP-HM La Conception- Biologie de la Reproduction-CECOS, Biologie de la Reproduction, Marseille, France
| | - A Martial
- CNRS- Centre Norbert Elias, Social Anthropology, Marseille, France
| |
Collapse
|